AIV Logo AIV Assistant

Loading...

Earnings Recaps

Browse reported earnings of the most popular stocks

164 companies Today
Airbnb, Inc. logo
AB
Airbnb, Inc.
ABNB
Q3 2025
Reported:

Airbnb delivered a strong Q3 2025, with revenue growth of 10% year-over-year and record adjusted EBITDA surpassing $2 billion, driven by strategic improvements and international expansion.

Key takeaways
  • Gross booking value increased 14% year-over-year, with nights booked rising 9%.
  • Successfully introduced 65 major service improvements, including enhanced payment flexibility and improved mapping features, boosting user experience.
  • International markets showed strong performance, with average nights booked growing at double the rate of core markets.
  • Launched service experiences with high customer satisfaction ratings, attracting new users and diversifying offerings.
  • Initiated a hotel pilot program in key cities, enhancing Airbnb’s portfolio and filling market gaps.
More info
Archer Aviation Inc. Class A Common Stock logo
AC
Archer Aviation Inc. Class A Common Stock
ACHR
Q3 2025
Reported:

Archer Aviation reported strong momentum in Q3 2025, highlighted by the strategic acquisition of Hawthorne Airport and a robust capital raise, positioning the company for rapid scaling and commercialization of its eVTOL technology.

Key takeaways
  • Secured a definitive agreement to acquire Hawthorne Airport, a key strategic asset located near LAX, enhancing Archer's operational capabilities ahead of the 2028 Olympics.
  • Successfully raised $650 million in equity capital, bolstering liquidity to over $2 billion.
  • Advanced testing of the Midnight aircraft, achieving significant milestones in range, flight time, and speeds with ongoing validation of operational performance.
  • Launched initial commercial operations in Abu Dhabi and established a partnership with Korean Air for up to 100 Midnight aircraft.
  • Focus on scaling production to meet certification and commercial deployment goals, with plans for 50 aircraft annually.
More info
Ameren Corporation logo
AE
Ameren Corporation
AEE
Q3 2025
Reported:

Ameren reported third quarter 2025 adjusted earnings of $2.17 per share, reflecting a strong year-over-year improvement driven by significant infrastructure investment and operational efficiencies.

Key takeaways
  • Adjusted earnings increased 16% from Q3 2024, aided by a $0.18 tax benefit excluded from adjusted figures.
  • Over $3 billion deployed in critical infrastructure upgrades in the first nine months of 2025, enhancing reliability and service capacity.
  • Ameren continues to anticipate earnings growth at a 6% to 8% compound annual rate through 2029, with updated 2025 EPS guidance raised to $4.90-$5.10.
  • Engagement with data center developers has expanded construction agreements to 3 gigawatts, signaling strong future demand and economic growth.
  • Electric rates remain competitive, below national and Midwest averages, supporting the company's commitment to customer affordability.
More info
Air France-KLM SA logo
AF
Air France-KLM SA
AF.PA
Q3 2025
Reported:

Air France-KLM demonstrated resilience in Q3 2025 with stable operating margins at 13.1%, a 3% revenue growth year-over-year, and a solid operating income improvement, despite facing external challenges.

Key takeaways
  • Revenues increased to EUR 9.2 billion, supported by a 5% rise in passenger traffic, totaling 29.2 million.
  • Operating income rose by EUR 23 million year-over-year to EUR 1.2 billion, reflecting effective cost management despite rising operational charges.
  • The loyalty program, Flying Blue, was recognized as the world's best airline loyalty program for the second consecutive year, enhancing customer engagement.
  • Almost one-third of the fleet is now composed of new generation aircraft, marking an 8-point increase from the previous year, supporting sustainability and efficiency goals.
  • Strategic network expansions include new destinations in Asia, the Caribbean, and North America, reinforcing market presence and connectivity.
More info
Aflac Incorporated logo
AF
Aflac Incorporated
AFL
Q3 2025
Reported:

Aflac Incorporated reported solid third-quarter 2025 results, with adjusted earnings per diluted share rising 15.3% year-over-year to $2.49, driven by strong sales performance in both Japan and the U.S.

Key takeaways
  • Aflac Japan recorded an impressive 11.8% year-over-year sales increase, notably fueled by a 42% surge in cancer insurance sales.
  • New sales in Aflac U.S. reached $390 million, marking a 2.8% increase from the previous year, maintaining a strong premium persistency of 79%.
  • Aflac repurchased a record $1 billion in shares and paid $309 million in dividends during the quarter, reinforcing its commitment to shareholder returns.
  • The company celebrated 43 consecutive years of dividend increases, highlighting its strong financial position and capital management strategy.
  • Continued emphasis on underwriting discipline and premium persistency is expected to drive further net earned premium growth, supporting the company’s long-term objectives.
More info
Assured Guaranty Ltd. logo
AG
Assured Guaranty Ltd.
AGO
Q3 2025
Reported:

Assured Guaranty Limited reported strong third-quarter results, achieving record highs in adjusted book value and operating income, bolstered by robust activity in the U.S. public finance sector.

Key takeaways
  • Adjusted operating income rose 17% year-over-year to $6.77 per share; adjusted book value per share reached a record $181.37.
  • Third quarter premium volume production (PVP) surged to $91 million, up 44% year-over-year, driven by a resurgence in U.S. municipal bond issuance.
  • Assured Guaranty secured 63% of the total insured U.S. municipal market par sold in the first nine months of 2025, emphasizing its industry leadership.
  • The company's investment portfolio benefitted from alternative investments, achieving an annualized internal rate of return of approximately 13% year-to-date.
  • A new $100 million share repurchase authorization reflects continued commitment to enhancing shareholder value.
More info
a.k.a. Brands Holding Corp. logo
AK
a.k.a. Brands Holding Corp.
AKA
Q3 2025
Reported:

No summary provided.

Key takeaways
  • Successfully opened Princess Polly's 11th store and enhanced its supply chain strategy to improve resilience and flexibility.
  • Year-to-date net sales increased by 5%, with adjusted EBITDA surpassing $17 million and gross margin expanding by 100 basis points.
  • Fourth-quarter net sales are tracking positive low single digits, indicating recovery as inventory levels stabilize.
  • Continuation of a focus on direct-to-consumer channels with trend-driven merchandising and robust digital marketing strategies, particularly on TikTok.
  • Expansion plans include 8 to 10 additional Princess Polly stores in 2026 and growing wholesale partnerships, particularly with Nordstrom and asos.com.
More info
Alpha Services and Holdings S.A. logo
AL
Alpha Services and Holdings S.A.
ALPHA.AT
Q3 2025
Reported:

Alpha Bank reported robust financial performance for the first nine months of 2025, achieving EUR 704 million in profits and a 13.9% return on tangible equity, driven by strong net interest income and strategic partnerships.

Key takeaways
  • Earnings per share reached EUR 0.27, representing 73% of the annual target, with a planned interim cash dividend of EUR 111 million.
  • The bank’s partnership with UniCredit deepened, as UniCredit increased its stake to approximately 30%, enhancing cross-border operational capabilities and client access.
  • Continued momentum in fee income from Asset and Wealth Management, along with solid growth in corporate lending, positions Alpha Bank favorably against peers.
  • EPS is projected to grow by 10% annually beyond 2025, supported by ongoing capital allocation to profitable loan growth and strategic initiatives.
More info
Amprius Technologies, Inc. logo
AM
Amprius Technologies, Inc.
AMPX
Q3 2025
Reported:

Amprius Technologies reported record Q3 2025 revenue of $21.4 million, a 42% sequential increase, driven by strong demand for its innovative silicon anode batteries, particularly in the aviation sector.

Key takeaways
  • Revenue surged 173% year-over-year, bolstered by over 80 new customers in Q3 alone.
  • The second-generation SiCore batteries significantly contributed to revenue, with shipments more than quadrupling compared to Q3 2024.
  • Approximately 75% of Q3 revenue originated from the aviation segment, primarily unmanned aerial systems (UAS).
  • The company achieved positive gross margins for the second consecutive quarter, enhancing financial performance amidst industry challenges.
More info
Alpha Metallurgical Resources, Inc. logo
AM
Alpha Metallurgical Resources, Inc.
AMR
Q3 2025
Reported:

Alpha Metallurgical Resources delivered solid Q3 results with adjusted EBITDA of $41.7 million and continued cost discipline, achieving the best cost of coal sales since 2021 at $97.27 per ton, though faced with declining metallurgical coal realizations.

Key takeaways
  • Adjusted EBITDA declined to $41.7 million from $46.1 million in Q2, maintaining shipment volumes of 3.9 million tons.
  • Metallurgical segment realizations decreased to a weighted-average of $117.62 per ton, down from $122.84 per ton in Q2.
  • Cost of coal sales successfully reduced to $97.27 per ton for the second consecutive quarter.
  • Unrestricted cash totaled $408.5 million, with total liquidity reaching $568.5 million, reflecting effective cash management.
  • Development production commenced at the Kingston Wildcat mine, targeting a full annual run rate of approximately 1 million tons by 2026.
More info
Aemetis, Inc. logo
AM
Aemetis, Inc.
AMTX
Q3 2025
Reported:

Aemetis reported a robust revenue increase of 13% year-over-year to $59.2 million, driven by strong biodiesel demand in India and improved ethanol margins, positioning the company for future growth.

Key takeaways
  • Revenues rose to $59.2 million, primarily from biodiesel orders in India and improved ethanol sales pricing.
  • Operating loss decreased due to higher volumes and reduced SG&A expenses.
  • Significant capacity increase in dairy renewable natural gas production with a new multi-dairy digester, on track to reach over 500,000 MMBtu by year-end.
  • $30 million Mechanical Vapor Recompression system expected to enhance ethanol production efficiency and increase cash flow by $32 million annually starting mid-2026.
  • Anticipation of strong cash flow growth in Q4 due to multiple income streams, including LCFS and Section 45Z credits.
More info
Artivion Inc. Common Stock logo
AO
Artivion Inc. Common Stock
AORT
Q3 2025
Reported:

Artivion delivered robust Q3 2025 results with constant currency revenue growth of 16% and adjusted EBITDA growth of 39%, driven by strong performance from stent grafts and On-X valves.

Key takeaways
  • Stent graft revenues surged 31% year-over-year, supported by the early adoption of AMDS, positioning it as a key growth driver.
  • On-X valves achieved a 23% revenue increase, benefiting from market share gains and the unique clinical advantages of the product.
  • The recent CMS reimbursement update for complex aortic procedures is expected to enhance the economic proposition of AMDS, further driving adoption.
  • Investment in expanded operational capacity in Austin, Texas indicates proactive measures to support anticipated growth in the On-X business.
  • Artivion maintains a strong pipeline of clinical evidence and promising early commercial traction across its product portfolio.
More info
Air Products and Chemicals, Inc. logo
AP
Air Products and Chemicals, Inc.
APD
Q4 2025
Reported:

Air Products delivered solid fiscal Q4 2025 results with earnings per share of $12.03, aligning with strategic goals amid ongoing macroeconomic challenges and a commitment to capital discipline.

Key takeaways
  • Achieved an operating income margin of 23.7% and a return on capital of 10.1%, meeting full-year guidance.
  • Announced $1.6 billion returned to shareholders, marking the 43rd consecutive year of dividend increases.
  • Targeting high single-digit EPS growth in fiscal 2026 despite anticipated helium headwinds and a cautious macroeconomic outlook.
  • Implementing significant cost-saving measures, including a headcount reduction of 3,600, expected to yield $250 million in annual savings.
  • Project NEOM is approximately 90% complete, with full ammonia production expected in 2027, supporting future growth initiatives.
More info
AppLovin Corporation logo
AP
AppLovin Corporation
APP
Q3 2025
Reported:

AppLovin delivered a robust Q3 with revenues of $1.405 billion, up 68% year-over-year, bolstered by strong performance in gaming advertising and a successful early launch of its self-service platform.

Key takeaways
  • Adjusted EBITDA reached $1.158 billion, reflecting a margin of 82%, with free cash flow up 92% year-over-year to $1.049 billion.
  • Significant share repurchase activity, with 1.3 million shares bought for $571 million and a new $3.2 billion authorization announced.
  • Anticipated Q4 revenue guidance of $1.570 billion to $1.6 billion, indicating 12% to 14% sequential growth, backed by strong execution and operational momentum.
  • Early traction from the self-service platform shows promising 50% week-over-week spend growth among new advertisers.
More info
Appian Corporation logo
AP
Appian Corporation
APPN
Q3 2025
Reported:

Appian delivered strong financial performance in Q3 2025, with total revenue growing 21% to $187 million, driven by solid increases in both cloud subscriptions and overall subscription revenues.

Key takeaways
  • Cloud subscriptions revenue rose 21% to $113.6 million, highlighting the resilience of Appian's core business.
  • The weighted Rule of 40 score improved to 39, reflecting enhanced go-to-market productivity and operational efficiency.
  • More than 25% of customers are now utilizing Appian AI solutions, showcasing strong market demand for integrated AI and process automation capabilities.
  • Appian's AI-driven automation is delivering significant ROI for customers, with reported enhancements in processing times across various business functions.
  • The company continues to be recognized as a leader in process orchestration and automation technologies, further solidifying its competitive position in the market.
More info
Arhaus Inc. Class A Common Stock logo
AR
Arhaus Inc. Class A Common Stock
ARHS
Q3 2025
Reported:

Arhaus delivered a robust third quarter in 2025, achieving record net revenue of $345 million and demonstrating strong brand demand with a 4.1% comparable growth rate.

Key takeaways
  • Net revenue increased 8% year-over-year, marking the highest third-quarter revenue in company history.
  • The Fall 2025 Collection was the most successful launch in Arhaus history, indicating strong consumer engagement and design leadership.
  • Record demand was recorded for September and for custom upholstery, driven by the successful introduction of innovative designs and a well-performing in-home design program.
  • New showroom openings, including a flagship location in Pasadena, California, are expected to enhance brand visibility and customer engagement.
  • Vertically integrated operations continue to provide Arhaus with quality control and supply chain resilience, particularly in upholstery production.
More info
Atmos Energy Corporation logo
AT
Atmos Energy Corporation
ATO
Q4 2025
Reported:

Atmos Energy delivered robust fiscal 2025 results, achieving a diluted EPS of $7.46—marking the 23rd consecutive year of growth—while also expanding its customer base and capital investments significantly.

Key takeaways
  • Added approximately 57,000 residential customers and nearly 3,200 commercial customers during fiscal '25, driving natural gas demand.
  • Consolidated capital spending rose to $3.6 billion, with 87% focused on enhancing safety and reliability of the gas distribution system.
  • Successful implementation of Texas House Bill 4384 enabled quicker capital recovery, allowing recovery of over 95% of spending within 6 months.
  • EPS growth target of 6% to 8% expected for fiscal '26, with plans to align dividend growth with this performance.
More info
AvePoint Inc. Class A Common Stock logo
AV
AvePoint Inc. Class A Common Stock
AVPT
Q3 2025
Reported:

AvePoint, Inc. delivered a strong performance in Q3 2025, outperforming revenue and non-GAAP operating income guidance as the demand for robust governance solutions in the AI landscape continues to rise.

Key takeaways
  • Revenues exceeded guidance, highlighting strong customer adoption of AvePoint's governance platform amid growing AI concerns.
  • 86% of surveyed companies delayed AI rollouts by up to 12 months due to security and governance issues, underscoring market demand for AvePoint's solutions.
  • Introduction of the enhanced AvePoint Confidence Platform offers improved visibility and lifecycle control for agentic AI, addressing critical compliance and data protection needs.
  • The launch of the operational efficiency Command Center allows clients to measure governance impact, elevating oversight to the Board level.
  • Strategic partnerships with major tech companies enhance governance integration across diverse SaaS and cloud environments, bolstering AvePoint's market position.
More info
Barrett Business Services, Inc. logo
BB
Barrett Business Services, Inc.
BBSI
Q3 2025
Reported:

BBSI reported strong Q3 2025 results, highlighted by an 8.6% increase in gross billings driven by record worksite employee additions, despite macroeconomic challenges impacting client hiring.

Key takeaways
  • Gross billings rose to $2.32 billion, an 8.6% year-over-year increase.
  • Added a record 10,400 worksite employees from new clients, contributing to a 6.1% total growth.
  • Staffing revenues declined 10% to $19 million due to client reluctance amid economic uncertainty.
  • Strong client retention maintained a high Net Promoter Score in the high 60s for three consecutive years.
  • Continued expansion in new markets with grand openings in Chicago and Dallas, and future plans for Nashville in January.
More info
Black Hills Corporation logo
BK
Black Hills Corporation
BKH
Q3 2025
Reported:

Black Hills Corp. reported strong Q3 2025 results, reaffirming its earnings guidance with a solid adjusted EPS of $0.45, reflecting strategic progress in regulatory and capital initiatives.

Key takeaways
  • Adjusted EPS increased to $0.45 from $0.35 year-over-year, aided by new rates and rider recoveries.
  • Concluded seven rate reviews since 2024, reinforcing regulatory strategy and customer growth.
  • Advancing a $1 billion capital plan, including completion of the Ready Wyoming transmission expansion by year-end.
  • Merger with NorthWestern Energy is progressing, expected to enhance competitiveness and unlock additional value for stakeholders.
  • Confidently reaffirming 2025 earnings guidance of $4 to $4.20 per share, aiming for upper-range EPS growth through 2026.
More info
BlackSky Technology Inc. logo
BK
BlackSky Technology Inc.
BKSY
Q3 2025
Reported:

BlackSky Technologies reported strong third-quarter performance, highlighted by over $60 million in new international contracts and significant progress in deploying its Gen-3 satellite capabilities, positioning the company well for future growth.

Key takeaways
  • Secured more than $60 million in new contracts, primarily from international customers, enhancing revenue diversification.
  • Awarded a $30 million contract to integrate Gen-3 ISR services for a strategic international defense client, underscoring demand for sovereign space capabilities.
  • International revenue now accounts for approximately 50% of total sales, with over 90% of backlog related to Gen-3 capabilities.
  • Cash balance increased by over 50% year-over-year, providing a stronger liquidity position with total cash exceeding $200 million.
  • Anticipating a robust fourth quarter as momentum from international contracts continues to build into 2026.
More info
BK Technologies Corporation logo
BK
BK Technologies Corporation
BKTI
Q3 2025
Reported:

BK Technologies reported robust third-quarter performance, achieving a 21% increase in revenue to $24.4 million, alongside significant gross margin improvement to 49.9%.

Key takeaways
  • Net income surged 46% to $3.4 million, equating to $0.87 per diluted share; non-GAAP adjusted EPS reached $1.27.
  • Strong demand for the BKR 9000 multiband radio contributed to sustained revenue growth and a favorable sales mix.
  • Cash and cash equivalents rose to $21.5 million with no debt, providing financial flexibility for strategic investments.
  • Operating income increased to $4.8 million, driving an operating margin of 19.8%, up from 12.9% year-over-year.
More info
Bloomin' Brands, Inc. logo
BL
Bloomin' Brands, Inc.
BLMN
Q3 2025
Reported:

Bloomin' Brands delivered solid operational improvements in Q3 2025, with management emphasizing a focused turnaround strategy centered on enhancing the guest experience and simplifying restaurant operations.

Key takeaways
  • Implemented operational changes, including menu simplifications and improved brand positioning, leading to enhanced guest satisfaction metrics.
  • Successfully refranchised restaurants in Brazil, streamlining corporate structure and reducing operational complexity.
  • Increased profitability through the introduction of value-driven offers in casual dining brands, boosting customer retention and table turnover.
  • Continued commitment to test-and-learn culture, with expanded testing of menu innovations and service enhancements across Outback restaurants.
  • Strong leadership team established, with significant operational experience, to drive the turnaround efforts across the brand portfolio.
More info
Blink Charging Co. logo
BL
Blink Charging Co.
BLNK
Q3 2025
Reported:

Blink Charging demonstrated strong operational progress in Q3 2025, achieving a 7.3% revenue increase year-over-year and significant improvements in gross margins and cash burn efficiency.

Key takeaways
  • Total revenue reached $27 million, with service revenue hitting a record $11.9 million, up 36% year-over-year.
  • Gross margins improved to 35.8%, driven by a focus on higher-margin products and service revenues.
  • Cash burn was reduced by 87% sequentially to $2.2 million, marking the lowest level in over three years.
  • The company is shifting from in-house manufacturing to third-party partnerships, enhancing focus on service revenue and operational efficiency.
  • Blink's transformation efforts have resulted in the elimination of $13 million in annualized expenses, reinforcing a path to profitability.
More info
Borr Drilling Limited logo
BO
Borr Drilling Limited
BORR
Q3 2025
Reported:

Borr Drilling Limited reported a robust Q3 2025, with a revenue increase of $9.4 million quarter-over-quarter and adjusted EBITDA growth to $135.6 million, while maintaining high utilization rates across its fleet.

Key takeaways
  • Revenue growth driven by increased day rates and bareboat chartering, with total operating revenues at $158.3 million.
  • Adjusted EBITDA margin remains strong at 48.9%, reflecting high operational efficiency.
  • Significant liquidity position with $461.8 million available, including $227.8 million in free cash.
  • Secured three contract extensions in Mexico, enhancing visibility into 2026 and beyond.
  • Optimistic outlook for Q4 2025 despite near-term transition impacts, with full-year adjusted EBITDA projected between $455 million and $470 million.
More info
Bowman Consulting Group Ltd. Common Stock logo
BW
Bowman Consulting Group Ltd. Common Stock
BWMN
Q3 2025
Reported:

Bowman Consulting achieved a significant milestone with a $500 million annualized gross revenue rate for Q3 2025, driven by 11% year-over-year net revenue growth and an 8% increase in adjusted EBITDA.

Key takeaways
  • Net revenue reached $112 million, supported by over 20% growth in transportation and power utility markets.
  • GAAP net income surged to $6.6 million, compared to just $800,000 in the same quarter last year.
  • Record backlog of $448 million grew nearly 18% year-over-year, indicating strong demand across key sectors.
  • Adjusted EPS doubled to $0.61, reflecting improved operational efficiency and growth in billed revenue.
  • Total overhead decreased as a percentage of net revenue, enhancing profit margins and capital efficiency.
More info
Commerzbank AG logo
CB
Commerzbank AG
CBK.DE
Q3 2025
Reported:

Commerzbank AG reported the best nine-month operating result in its history, driven by strong growth in corporate loans and fee income, positioning the bank favorably for continued momentum into 2026.

Key takeaways
  • Achieved 13% loan growth in Corporate Clients and an 11% increase in total revenues, underscoring robust client relationships.
  • Cost-income ratio improved to 56%, aligning with strategic goals towards enhanced efficiency.
  • Return on tangible equity reached 10% (excluding restructuring charges), establishing a new baseline for future growth.
  • Successful implementation of an employee share program aimed at enhancing shareholder value and engagement.
  • Strong potential from the German stimulus package expected to boost economic growth and banking performance in the coming years.
More info
CareCloud Inc. Common Stock logo
CC
CareCloud Inc. Common Stock
CCLD
Q3 2025
Reported:

CareCloud, Inc. reported a robust 9% year-over-year revenue increase to $31.1 million in Q3 2025, successfully executing two strategic acquisitions that expand its market presence and capabilities.

Key takeaways
  • Revised full-year revenue guidance raised to $117-$119 million, up from $111-$114 million, underpinned by strong operational momentum.
  • Adjusted EBITDA increased 13% year-over-year to $7.7 million, highlighting effective cost management and operational leverage.
  • Completion of the Medsphere acquisition enhances CareCloud's offerings in the inpatient market, positioning the company for significant growth across the healthcare continuum.
  • The acquisition of Map App strengthens CareCloud's analytics and benchmarking capabilities, further solidifying its value proposition in the hospital sector.
  • No dilution to common shareholders during acquisitions, demonstrating disciplined capital allocation strategies and improved cash flow management.
More info
Chimera Investment Corporation logo
CI
Chimera Investment Corporation
CIM
Q3 2025
Reported:

Chimera Investment Corporation reported a GAAP net loss of $22 million for Q3 2025, yet successfully closed the acquisition of HomeXpress, positioning itself for future growth and revenue diversification.

Key takeaways
  • HomeXpress acquisition closed for $267 million, expected to significantly enhance earnings and diversification.
  • Year-to-date economic return on GAAP book value stood at 8.3%, despite a negative return of 1.4% in Q3.
  • HomeXpress originated $2.4 billion in loans through September, with projected Q4 originations of $1 billion yielding $13 million to $15 million in after-tax earnings.
  • Management anticipates long-term economic benefits from the integration of HomeXpress and Palisades, enhancing both operational efficiency and market reach.
More info
Clarus Corporation logo
CL
Clarus Corporation
CLAR
Q3 2025
Reported:

Clarus Corporation reported a modest 3% increase in net sales to $69.3 million for Q3 2025, bolstered by strong demand in the Outdoor segment and improvements in operational efficiency, despite ongoing macroeconomic challenges.

Key takeaways
  • Adjusted EBITDA grew by 15% year-over-year, reflecting improvements in organizational structure and product focus.
  • The revamped Black Diamond apparel line achieved a remarkable 29% sales growth, indicating positive market reception.
  • Operating expenses (SG&A) decreased by $600,000 compared to the previous year, contributing to enhanced profitability.
  • Despite tariff pressures and FX losses impacting margins, strategic pricing adjustments are planned to restore profitability alongside inventory rationalization.
More info
ConocoPhillips logo
CO
ConocoPhillips
COP
Q3 2025
Reported:

ConocoPhillips reported strong third-quarter performance, exceeding production guidance and raising its full-year outlook while enhancing shareholder returns, including an 8% dividend increase.

Key takeaways
  • Produced 2.4 million barrels of oil equivalent per day, surpassing guidance and establishing a solid foundation for 2026.
  • Adjusted earnings of $1.61 per share and generated $5.4 billion in cash from operations, with total shareholder returns reaching $7 billion year-to-date.
  • Capital expenditures decreased to $2.9 billion as the company transitions past peak investment cycles, while full-year production guidance was raised to 2.375 million barrels per day.
  • Project capital estimate for Willow increased to $8.5–9 billion due to inflation, but project timeline remains on track for first oil in early 2029.
  • Strategic asset sales program progressing well, with $3 billion completed toward a $5 billion target, indicating strong portfolio management and cash flow enhancement.
More info
Corpay, Inc. logo
CP
Corpay, Inc.
CPAY
Q3 2025
Reported:

Corpay reported robust Q3 2025 results with 14% revenue and cash EPS growth, driven by strong performance in both the Vehicle and Corporate Payments segments.

Key takeaways
  • Q3 organic revenue growth reached 11%, with Corporate Payments up 17% despite a slight flow compression.
  • Retention improved to 92.4%, and new bookings surged 24%, indicating strong client engagement.
  • Q4 revenue guidance raised to $1.235 billion, with an expected cash EPS of $5.90, fueled by recent acquisitions and strong ongoing trends.
  • The company projects 2026 revenue growth of 9% to 11%, underpinned by favorable macroeconomic conditions and estimated incremental accretion from recent M&A transactions.
More info
RH logo
CR
RH
CRH
Q3 2025
Reported:

CRH achieved a record third quarter in 2025, raising its adjusted EBITDA guidance for the year, driven by strong market demand, strategic acquisitions, and operational efficiency.

Key takeaways
  • Total revenues reached $11.1 billion, up 5% year-over-year, with adjusted EBITDA of $2.7 billion representing a 10% increase.
  • A 100 basis point expansion in adjusted EBITDA margin reflects ongoing focus on operational performance.
  • Year-to-date, CRH has invested $3.5 billion in 27 acquisitions, indicating robust pipeline and commitment to future growth.
  • Positive market trends in infrastructure, particularly in transportation and water sectors, position the company for substantial above-market growth.
  • Full year adjusted EBITDA is now forecasted between $7.6 billion and $7.7 billion, supporting a continued trajectory of success.
More info
Cresco Labs Inc. logo
CR
Cresco Labs Inc.
CRLBF
Q3 2025
Reported:

Cresco Labs reported a modest revenue growth of 1% to $165 million in Q3 2025 while making strategic moves to strengthen the balance sheet and focus on core markets for sustainable growth.

Key takeaways
  • Adjusted EBITDA reached $40 million, reflecting disciplined execution and a focus on cash-generating operations.
  • Completed debt refinancing, enhancing financial flexibility and positioning for future investments and M&A opportunities.
  • Exited California operations, reducing liabilities and organizational complexity to concentrate on more profitable ventures.
  • Maintained #1 retail share in Ohio with successful new dispensary openings planned for early 2026, while preparing to enter Kentucky's medical market.
  • Set to launch flagship Cresco branded products in Germany, marking the company's entry into the European Union market.
More info
Carriage Services, Inc. logo
CS
Carriage Services, Inc.
CSV
Q3 2025
Reported:

Carriage Services delivered solid third-quarter results, with total operating revenue increasing 5.2% year-over-year to $101.3 million, bolstered by a significant 21.4% rise in preneed cemetery sales and strong growth in general agency commission revenue.

Key takeaways
  • Preneed cemetery sales surged 21.4% year-over-year, reflecting renewed momentum and robust demand.
  • Adjusted consolidated EBITDA rose to $33 million, marking a 7.3% increase, with margins expanding by 160 basis points to 32.1%.
  • Adjusted diluted earnings per share increased 17.2% to $0.75 from $0.64 in the prior year, emphasizing effective operational strategies and financial management.
  • The company is set to enhance sales capabilities through the launch of Sales Edge 2.0 and Titan, an AI-powered sales agent, aimed at further accelerating growth in preneed sales.
More info
CoreCivic, Inc. logo
CX
CoreCivic, Inc.
CXW
Q3 2025
Reported:

CoreCivic reported strong contract activations in Q3 2025, projecting significant earnings growth driven by new detention facility contracts, although initial start-up costs are expected to impact Q4 performance.

Key takeaways
  • Secured four new contracts with total expected annual revenue of approximately $320 million, enhancing 2026 revenue projections.
  • Full-year 2025 financial guidance indicates an anticipated annual revenue run rate of $2.5 billion and EBITDA exceeding $450 million once facilities reach stabilized occupancy.
  • ICE detention populations reached historical highs, suggesting potential for increased demand from government partners.
  • Ongoing share repurchase program saw $121 million in shares bought back year-to-date, indicating strong management confidence in stock valuation.
  • Company maintains approximately 24,000 available beds, poised to accommodate additional government demand.
More info
Box, Inc. logo
DB
Box, Inc.
DBX
Q3 2025
Reported:

Dropbox reported strong Q3 2025 results, with revenue surpassing guidance due to improved retention in its product offerings, particularly the newly enhanced Dash platform.

Key takeaways
  • Constant currency revenue exceeded guidance, driven by robust retention rates across individual and self-serve plans.
  • Non-GAAP operating margin improved year-over-year, reflecting enhanced operational efficiency.
  • The Dash platform saw significant upgrades, including a 75% reduction in search latency and new multimodal capabilities, enhancing overall user experience.
  • Early engagement metrics for Dash indicate strong adoption, with 60% of weekly active users utilizing the tool at least two days per week.
  • Dropbox is rolling out native Dash integration within its FSS app, broadening access to its SMB customer base and driving trial conversions.
More info
Definitive Healthcare Corp. Class A Common Stock logo
DH
Definitive Healthcare Corp. Class A Common Stock
DH
Q3 2025
Reported:

Definitive Healthcare reported Q3 2025 results with $60 million in revenue, slightly down from last year but exceeding guidance, driven by improved operational efficiency and customer retention rates.

Key takeaways
  • Adjusted EBITDA reached $18.9 million, a margin of 32%, surpassing the high end of guidance by $2 million.
  • Customer count remained stable at 2,400, with a notable increase of 10 enterprise customers, the highest level since Q3 last year.
  • Continued focus on differentiated data led to significant wins in customer engagements, solidifying competitive advantages in the market.
  • Year-over-year retention rates improved, reflecting positive trends in customer satisfaction and operational execution.
More info
Dine Brands Global, Inc. logo
DI
Dine Brands Global, Inc.
DIN
Q3 2025
Reported:

Dine Brands' Q3 2025 results reflect resilience amidst a competitive landscape, with Applebee's achieving positive comp sales while IHOP faced a slight downturn, driven by strategic menu innovations and robust marketing efforts.

Key takeaways
  • Applebee's reported a 3.1% increase in comparable sales and maintained positive comp traffic for the second consecutive quarter.
  • IHOP's comparable sales declined by 1.5%, although value offerings remained a focus for the brand.
  • Adjusted EBITDA decreased to $49 million from $61.9 million year-over-year, highlighting the industry's pressures.
  • The introduction of targeted menu items, like Chicken Parmesan Fettuccine and the Ultimate Trio appetizer, significantly contributed to sales and guest engagement.
  • Enhanced marketing efforts yielded a 266% increase in social media engagement, underscoring the brand's commitment to modernizing the guest experience.
More info
Krispy Kreme Inc. Common Stock logo
DN
Krispy Kreme Inc. Common Stock
DNUT
Q3 2025
Reported:

Krispy Kreme's Q3 2025 results show promising progress in its turnaround strategy, marked by a focus on refranchising, cost efficiency, and strategic partnerships that are enhancing profitability and expanding market reach.

Key takeaways
  • Continued refranchising efforts expected to enhance profitability and reduce net debt while exploring international growth opportunities.
  • Operational efficiencies and cost reductions are driving margin expansion, especially through optimized production and logistics.
  • Addition of approximately 1,000 profitable doors with strategic partners, supporting strong sales growth in high-margin segments like Target and Walmart.
  • Digital sales in the U.S. rose 17% year-over-year, reflecting effective marketing and engagement strategies.
More info
DigitalOcean Holdings, Inc. logo
DO
DigitalOcean Holdings, Inc.
DOCN
Q3 2025
Reported:

DigitalOcean delivered a robust third quarter, outperforming expectations with 16% revenue growth and record organic ARR, bolstered by strong demand from AI-native and digital enterprise customers.

Key takeaways
  • Revenue reached $230 million, the highest growth rate since Q3 2023, with $44 million in organic incremental ARR.
  • Adjusted EBITDA and non-GAAP EPS exceeded guidance, achieving a trailing 12-month adjusted free cash flow margin of 21%.
  • Revenue from customers with over $1 million in annual run rate grew 72% year-over-year, highlighting increased retention and spending.
  • The company's expanding AI infrastructure is attracting significant traction among major AI-native companies, enhancing future growth potential.
  • DigitalOcean's balance sheet was strengthened through strategic equipment leasing and the repurchase of its 2026 convertible debt.
More info
electroCore, Inc. logo
EC
electroCore, Inc.
ECOR
Q3 2025
Reported:

electroCore's Q3 2025 results reflect a strategic pivot aimed at accelerating growth through key investments and acquisitions, despite a temporary delay in profitability.

Key takeaways
  • Delivered robust revenue growth in the VA channel, secured a new 5-year contract, and expanded sales capabilities.
  • Acquired NeuroMetrix's Quell portfolio, enhancing product offerings and diversifying revenue streams with a new FDA-cleared device for fibromyalgia.
  • Initiated targeted investments in technology and personnel to support growth in both medical and wellness divisions, positioning the company for future success.
More info
Flex Ltd. logo
EF
Flex Ltd.
EFX.TO
Q3 2025
Reported:

Enerflex delivered robust third-quarter results, driven by strong performance in its energy infrastructure and aftermarket services divisions, alongside strategic expansions in North America and international markets.

Key takeaways
  • Engineered Systems hit a new revenue record, bolstered by a $1.1 billion backlog and a book-to-bill ratio of 0.9x, indicating solid demand.
  • Increased contract compression fleet utilization to 94%, with plans to expand to 485,000 horsepower by 2026 amid rising natural gas production in the Permian.
  • Secured a significant contract for a 200 mmcfd cryogenic gas processing facility in the U.S. and achieved rapid project completions across international projects, including Oman and Argentina.
  • Declared a dividend increase as part of disciplined capital allocation strategy, reflecting confidence in financial strength and growth prospects moving forward.
More info
Eos Energy Enterprises, Inc. logo
EO
Eos Energy Enterprises, Inc.
EOSE
Q3 2025
Reported:

Eos Energy achieved record third-quarter revenue, driven by increased order bookings and strategic partnerships, positioning the company for sustainable growth and profitability.

Key takeaways
  • Delivered the highest revenue quarter in company history, signaling strong operational performance and demand.
  • Secured significant customer cash inflows totaling $43 million in Q4, demonstrating improved financial stability.
  • Established a strategic agreement with Talen Energy, enhancing operational capabilities and market presence.
  • Commenced plans for a new optimized factory and software hub in Pittsburgh to bolster production efficiency and innovation.
  • Continued investment in human capital with low turnover rates, attracting top talent to support growth initiatives.
More info
Eversource Energy logo
ES
Eversource Energy
ES
Q3 2025
Reported:

Eversource Energy's Q3 2025 results demonstrate strong operational execution and strategic progress, positioning the company favorably among its peers with a year-to-date top performance in share price.

Key takeaways
  • Achieved a top decile reliability performance and a significant improvement in the funds from operations (FFO) to debt ratio due to favorable regulatory outcomes.
  • On track to invest nearly $5 billion in transmission and distribution infrastructure this year, enhancing the company’s operational strength.
  • Weather-normalized load growth of 2% year-to-date, with summer peak demand reaching over 12 gigawatts, indicating robust growth driven by electrification and decarbonization initiatives.
  • Progress on significant projects: construction of the Revolution Wind project is nearly complete, with back-feed energization anticipated by November.
  • Strategic collaboration with the new PURA commissioners aims to foster balanced regulatory outcomes beneficial for stakeholders and customers.
More info
Esperion Therapeutics, Inc. logo
ES
Esperion Therapeutics, Inc.
ESPR
Q3 2025
Reported:

Esperion Therapeutics reported a strong Q3 2025 with a 69% year-over-year revenue increase, leveraging strategic investments and marketing efforts to drive prescription growth amid heightened recognition of its bempedoic acid products.

Key takeaways
  • Total revenue reached $87.3 million, driven by a 31% year-over-year growth in U.S. net product revenue.
  • The company secured agreements with four generic manufacturers to protect its NEXLETOL franchise through April 2040, enhancing long-term value.
  • Increased prescriber engagement and strategic marketing aimed at statin-intolerant patients contributed to improved brand awareness and prescription growth.
  • The introduction of bempedoic acid products in ESC/EAS guidelines marks a significant clinical validation, with expectations for U.S. guideline inclusion in early 2026.
  • An 87% average approval rate for Medicare coverage reflects successful efforts in enhancing patient access.
More info
Evaxion Biotech A/S logo
EV
Evaxion Biotech A/S
EVAX
Q3 2025
Reported:

Evaxion reported a strong Q3 2025, highlighted by a transformative deal with MSD, marking a significant milestone in their AI-driven vaccine development and extending their cash runway into 2027.

Key takeaways
  • MSD exercised their option on the AI-discovered vaccine candidate EVX-B3, generating a $7.5 million exercise fee that enhances financial stability.
  • Two-year clinical efficacy data for EVX-01 showed a promising 75% objective overall response, generating sustained T cell activity across patients.
  • Introduction of EVX-04, targeting acute myeloid leukemia, expands Evaxion’s pipeline, underscoring their commitment to precision cancer vaccines.
  • Investment in an upgraded AI-Immunology platform with an automated vaccine design module optimizes development processes and cost efficiency.
  • Cash runway extended to the second half of 2027, ensuring ongoing R&D and business development initiatives.
More info
Evergy, Inc. logo
EV
Evergy, Inc.
EVRG
Q3 2025
Reported:

Evergy's third quarter 2025 results show slight year-over-year adjusted earnings growth, driven by recovered regulated investments despite adverse weather impacts. The company has a strong outlook bolstered by significant demand growth opportunities.

Key takeaways
  • Adjusted EPS for Q3 2025 is $2.03, up from $2.02 a year earlier, while year-to-date EPS has decreased slightly to $3.41 from $3.46.
  • The company narrowed its 2025 adjusted EPS guidance to $3.92-$4.02, primarily due to weather-related challenges that impacted earnings by $0.13 per share.
  • Evergy announced a 4% increase in its quarterly dividend, reflecting confidence in its updated growth outlook and commitment to a 60%-70% payout ratio.
  • Strong interest from large customers is evident with a robust economic development pipeline, including a transformative 4-6 gigawatt opportunity projected to enhance regional growth and job creation.
  • Operational performance remains strong, with generation availability and grid reliability both exceeding target metrics through September.
More info
Expensify Inc. Class A Common Stock logo
EX
Expensify Inc. Class A Common Stock
EXFY
Q3 2025
Reported:

Expensify delivered robust performance in Q3 2025 with revenue of $35.1 million and significant growth in travel bookings, supporting strategic new customer wins and product advances.

Key takeaways
  • Revenue increased to $35.1 million with average paid members rising to 642,000.
  • Travel bookings soared 95% since Q1, underscoring strong demand for Expensify Travel.
  • Non-GAAP net income reached $4.3 million, with adjusted EBITDA at $6.5 million.
  • Completed significant migration to New Expensify, targeting 90% feature parity with Classic.
  • Initiated stock repurchase program totaling $3 million to enhance shareholder value.
More info
Expedia Group, Inc. logo
EX
Expedia Group, Inc.
EXPE
Q3 2025
Reported:

Expedia Group's Q3 2025 results surpassed expectations with a 12% increase in bookings and a 9% rise in revenue, driven by strong demand and disciplined execution across its strategic priorities.

Key takeaways
  • Booked room nights increased 11%, with significant growth in B2B bookings, up 26%, marking 17 consecutive quarters of double-digit growth.
  • Positive shifts in the U.S. market and high double-digit growth in EMEA and Asia demonstrate strong consumer demand.
  • Continued enhancements in traveler experience through AI integration and improved loyalty programs resulted in double-digit growth in vacation rentals.
  • The company is raising its full-year guidance based on current trends and robust performance across its brands, particularly Expedia and Vrbo.
  • Strong advertising performance, with a record number of active partners, shows effective monetization strategies and AI-driven improvements in targeting.
More info
FI
Simplify Macro Strategy ETF
FIG
Q3 2025
Reported:

Figma achieved a record Q3 2025 with $274 million in revenue, marking a 38% year-over-year increase and surpassing guidance, while the company accelerated its product innovation and AI investment strategy.

Key takeaways
  • Revenue exceeded $1 billion in annual revenue run rate, with a record sequential net revenue increase.
  • Net dollar retention rose to 131%, reflecting increased adoption of new products.
  • Non-GAAP operating margin stood at 12% with adjusted free cash flow margin at 18%, despite significant investments in talent and AI.
  • Launched over 50 new features in Q3 to enhance customer experience and drive product velocity.
  • Strategic focus on AI integration and platform interoperability is expanding Figma's reach across diverse customer teams and industries.
More info
Leonardo S.p.a. logo
FI
Leonardo S.p.a.
FINMY
Q3 2025
Reported:

Leonardo reported strong third-quarter results for 2025, with new orders up 24.3% and revenues increasing by 12.4%, reflecting robust performance across all divisions.

Key takeaways
  • New orders reached EUR 18 billion year-over-year, driven by solid performances in electronics, naval, and defense sectors.
  • Revenue rose to EUR 13.4 billion, with EBITDA growing 22.7% to EUR 945 million.
  • Net debt decreased by 25.9%, indicating improved financial health and operational efficiency.
  • Prominent contracts, including a EUR 2 billion deal with the Kuwait Air Force, significantly contributed to strong sales.
  • The company is adapting well to market dynamics with a favorable outlook on future orders and strategic partnerships.
More info
Five9, Inc. logo
FI
Five9, Inc.
FIVN
Q3 2025
Reported:

Five9 reported a strong Q3, driven by a robust 80% year-over-year growth in enterprise AI bookings and a significant increase in both profitability and cash flow.

Key takeaways
  • Subscription revenue rose 10% year-over-year, with enterprise AI revenue growing 41%.
  • Adjusted EBITDA margin increased to 25%, marking a 37% year-over-year growth.
  • Record free cash flow grew 84% year-over-year, achieving a margin of 13%.
  • Five9's strategic positioning in the AI-powered customer experience (CX) market is strengthened by a rich data advantage and innovative AI integration capabilities.
  • Recognition as a leader in both Gartner's 2025 Magic Quadrant and IDC's inaugural MarketScape underscores Five9's competitive edge and industry leadership.
More info
Flowers Foods, Inc. logo
FL
Flowers Foods, Inc.
FLO
Q3 2025
Reported:

Flowers Foods demonstrated resilient performance in Q3 2025, strategically aligning its portfolio amidst category pressures, particularly in the bread sector, while continuing to invest in innovation.

Key takeaways
  • Despite ongoing challenges in the bread category due to economic factors, early signs of stabilization are emerging, with expectations for improved demand going into 2026.
  • The company is committed to long-term consumer-focused investments, even as innovation pressures short-term margins.
  • Successful integration of Simple Mills is yielding positive results, with collaborative efforts driving growth and fostering innovation for future products.
  • Management expressed gratitude for the contributions of retiring CFO Steve Kinsey, highlighting the leadership stability as a factor for continued progress.
  • The branded retail business outperformed expectations, while foodservice segments faced headwinds typical in the current economic climate.
More info
Funko, Inc. logo
FN
Funko, Inc.
FNKO
Q3 2025
Reported:

Funko's third quarter results for 2025 reveal strong operational momentum, driven by a significant brand presence and renewed licensing agreements, positioning the company for future growth.

Key takeaways
  • Achieved milestone of 1 billion units sold, emphasizing robust consumer demand.
  • Active fan loyalty program membership grew by 27% year-to-date, highlighting increased customer engagement.
  • Secured multiyear licensing renewals with major partners, including Disney and Warner Bros, strengthening the company’s competitive advantage.
  • The new "Make Culture POP!" strategy focuses on expanding product categories and enhancing speed to market for new trends.
  • Diversified retail presence with over 1,400 global partners, ensuring broad market reach.
More info
Fresenius SE & Co. KGaA logo
FR
Fresenius SE & Co. KGaA
FRE.DE
Q3 2025
Reported:

Fresenius reported a robust third quarter, with a significant EBIT growth guidance upgrade from 3-7% to 4-8%, supported by a strong performance in its Kabi and Helios segments.

Key takeaways
  • Core EPS surged by 14%, highlighting strong bottom-line performance driven by margin expansion and top-line growth.
  • Kabi achieved an impressive 16.7% EBIT margin, bolstered by newly launched products and strong progress in IV generics and biosimilars.
  • The Helios division maintained solid EBIT margins, showcasing resilience amid macroeconomic challenges.
  • Fresenius launched three new products focused on high-energy and protein needs in Q3, enhancing its MedTech portfolio.
  • The company returned to its self-imposed cash flow target corridor, reflecting disciplined financial management.
More info
JFrog Ltd. logo
FR
JFrog Ltd.
FROG
Q3 2025
Reported:

JFrog delivered a robust Q3 2025 performance with total revenue of $136.9 million, reflecting a 26% year-over-year growth and a strong commitment to cloud and security solutions.

Key takeaways
  • Cloud revenue increased to $63.4 million, achieving 50% growth year-over-year, driven by rising usage of AI-generated artifacts and software packages.
  • The number of enterprise customers grossing over $1 million annually grew by 54% year-over-year, now totaling 71 clients.
  • Net dollar retention stood at 118% for the trailing four quarters, showcasing continued expansion and customer loyalty in cloud adoption and security offerings.
More info
FRP Holdings, Inc. logo
FR
FRP Holdings, Inc.
FRPH
Q3 2025
Reported:

FRP Holdings reported a substantial decline in net income for Q3 2025, primarily impacted by acquisition-related expenses; however, adjusted net income improved, reflecting resilient operations amidst strategic developments.

Key takeaways
  • Net income decreased 51% year-over-year to $700,000, largely due to $1.3 million in one-time acquisition expenses from Altman Logistics.
  • Adjusted net income, excluding these expenses, increased by 21%, indicating stronger operational performance.
  • The pro rata share of NOI fell 16% to $9.5 million, though adjusted NOI rose slightly, demonstrating resilience amidst significant royalty impacts.
  • Occupancy challenges persist in the Commercial and Industrial segment, with a 24% decline, stressing the need for lease and occupancy improvements.
  • FRP's development pipeline remains robust, with key projects scheduled for completion by 2026, enhancing long-term growth prospects.
More info
Fortuna Silver Mines Inc. logo
FS
Fortuna Silver Mines Inc.
FSM
Q3 2025
Reported:

Fortuna Mining Corp. delivered robust Q3 2025 results, marked by significant operational achievements and a strong financial performance, including an attributable net income of $123.6 million.

Key takeaways
  • Achieved a gold price of $3,467 per ounce, contributing to a $123.6 million attributable net income and strong free cash flow of $73 million.
  • Secured a solid liquidity position with $588 million in cash and $266 million in net cash, enabling future growth investments.
  • Advanced growth projects like Diamba Sud in Senegal and Séguéla in Côte d'Ivoire, which are expected to substantially increase annual gold production.
  • Maintained all-in sustaining costs within guidance, with Lindero trending lower and Séguéla impacted by capital investment and higher royalty payments.
  • Strong focus on safety, achieving 318 days without a lost time injury and an improved total recordable injury frequency rate of 0.86.
More info
Fortinet, Inc. logo
FT
Fortinet, Inc.
FTNT
Q3 2025
Reported:

Fortinet reported strong third-quarter 2025 results, with total billings growing 14% year-over-year to $1.81 billion, driven by robust demand across its cybersecurity solutions, particularly in Unified SASE and SecOps.

Key takeaways
  • Unified SASE billings surged 19%, with FortiSASE achieving over 100% growth, positioning Fortinet as a SASE market leader.
  • Total revenue rose 14% to $1.72 billion, reflecting strong sales performance globally, particularly in EMEA and APAC.
  • The number of large enterprise deals exceeding $1 million climbed by 26%, highlighting Fortinet's expanding footprint among larger clients.
  • SecOps billing increased 33%, fueled by growing adoption of AI-driven security solutions as part of its comprehensive cybersecurity portfolio.
  • Fortinet's operational technology solutions also saw more than 30% billing growth, showcasing its strength in critical infrastructure security.
More info
Genpact Limited logo
G
Genpact Limited
G
Q3 2025
Reported:

Genpact Limited delivered robust Q3 2025 results, with a 7% year-over-year revenue increase to $1.291 billion, driven by the accelerated growth of Advanced Technology Solutions, which surged 20%. The company also reported significant adjusted EPS growth of 14% year-over-year.

Key takeaways
  • Advanced Technology Solutions, which now represents over 50% of revenue growth, reflects strong momentum with five consecutive quarters of accelerating growth.
  • Adjusted operating income margin expanded to 17.7%, and gross margin improved to 36.4%, indicating healthy profitability amid strategic investments.
  • The launch of new innovative products such as AI Maestro and dedicated agentic suites enhances Genpact's competitive position and market share potential.
  • Year-to-date, over 30% of awarded agentic contract value has come from new clients, showcasing successful client acquisition efforts.
  • Core Business Services also demonstrated steady growth, rising 3% year-over-year, supported by strong demand in Digital Operations and technology services.
More info
GDI Integrated Facility Services Inc. logo
GD
GDI Integrated Facility Services Inc.
GDI.TO
Q3 2025
Reported:

GDI Integrated Facility Services reported Q3 2025 revenue of $615 million, reflecting a 4% year-over-year decline, while adjusted EBITDA remained stable at $38 million. The company anticipates stabilization and recovery in its business services segments in 2026.

Key takeaways
  • Revenue decline mainly attributed to a 4% organic decrease alongside earlier business disposals.
  • Technical Services demonstrated resilience with a record adjusted EBITDA of $19 million, despite economic uncertainties.
  • Business Services USA faced a significant 12% organic decline, primarily due to the loss of a major client and a shift away from low-margin accounts.
  • GDI successfully reduced long-term debt by $26 million, enhancing its capacity for future growth through mergers and acquisitions.
  • Management expects organic growth to stabilize in the first half of 2026, even amidst challenging market conditions.
More info
Grupo Financiero Banorte, S.A.B. de C.V. logo
GF
Grupo Financiero Banorte, S.A.B. de C.V.
GFNORTEO.MX
Q3 2025
Reported:

Grupo Financiero Banorte reported strong third-quarter results despite a sequential net income decrease of 11%, influenced by extraordinary items. The core business showcases impressive resilience and growth across multiple segments, supported by effective margin management and capital optimization.

Key takeaways
  • Integrated margin expansion reflects cost of fund optimization and stronger consumer demand.
  • Net income experienced an 11% decline sequentially but remains 1% higher on an accumulated basis for the year.
  • ROE for the first nine months was solid at 22.3%, aligning with annual guidance.
  • The insurance business grew 20% year-to-date, significantly driven by increased billing and lending activity.
  • Loan portfolio, excluding government loans, expanded 10% year-over-year, primarily fueled by consumer lending growth.
More info
Global Net Lease, Inc. logo
GN
Global Net Lease, Inc.
GNL
Q3 2025
Reported:

Global Net Lease (GNL) reported a robust performance in Q3 2025, achieving significant milestones in portfolio optimization, debt reduction, and operational stability, highlighted by an investment-grade credit rating from Fitch.

Key takeaways
  • Successfully executed a $1.8 billion sale of a multi-tenant retail portfolio, driving approximately $2 billion in net debt reduction since Q3 2024.
  • Enhanced financial flexibility through a refinancing of the revolving credit facility, resulting in a 35 basis point reduction in interest rate spread and extending debt maturity to 2030.
  • Share repurchase program completed with 12.1 million shares bought back at a weighted average price of $7.59, offering an AFFO yield of approximately 12%.
  • Portfolio remains strong with 97% occupancy across over 850 properties, predominantly occupied by investment-grade tenants (60%).
  • Continued strong leasing activity with renewal spreads averaging 26% above prior rents, underscoring the resilience of GNL's tenant base.
More info
Genworth Financial, Inc. logo
GN
Genworth Financial, Inc.
GNW
Q3 2025
Reported:

Genworth Financial reported solid Q3 2025 results with net income of $116 million, bolstered by strong performance from its mortgage insurance subsidiary, Enact, which contributed significantly to earnings and capital returns.

Key takeaways
  • Adjusted operating income was $17 million, or $0.04 per share, reflecting resilience amidst market conditions.
  • Enact's strong cash flows led to $110 million in capital returns this quarter, totaling $1.2 billion since its IPO.
  • Genworth's long-term care (LTC) initiatives saw $44 million in gross incremental premium approvals with a significant average increase of 63%.
  • The CareScout network expanded to over 700 providers, achieving over 2,500 matches for LTC policyholders year-to-date, exceeding initial goals.
  • Strategic acquisition of Seniorly enhances CareScout's offerings, positioning Genworth for increased market share among aging consumers seeking care solutions.
More info
Gold Resource Corporation logo
GO
Gold Resource Corporation
GORO
Q3 2025
Reported:

Gold Resource Corporation demonstrated signs of operational turnaround in Q3 2025, achieving significant production improvements and a solid cash position amid challenging market conditions.

Key takeaways
  • Strong cash position of over $9 million, bolstered by successful capital raising and disciplined cash management.
  • Commencement of production from the new high-grade Three Sisters area, validating prior expectations and enhancing profitability through improved mining methods.
  • Mining gross profit achieved during the quarter marks a key milestone on the path back to profitability despite cash costs remaining above long-term targets.
  • Record high precious metal prices have positively influenced cash flows, particularly through increased silver content in mined materials.
  • Steps taken to enhance workplace safety following multiple lost time injury incidents, including hiring an external consultant for a comprehensive safety assessment.
More info
GeoPark Limited logo
GP
GeoPark Limited
GPRK
Q3 2025
Reported:

GeoPark Limited delivered strong third-quarter results, marked by increased production and a notable shift towards growth in Argentina following the acquisition of two new operational blocks in Vaca Muerta.

Key takeaways
  • Average consolidated production rose to 28,136 boe/d, exceeding 2025 guidance and a 3% increase quarter-over-quarter.
  • Adjusted EBITDA reached USD 71.4 million with a 57% margin; net income of USD 15.9 million showed significant recovery from prior losses.
  • The company plans to maintain a revised dividend program totaling approximately USD 6 million over the next four quarters while focusing on growth investments.
  • GeoPark successfully repurchased USD 108 million of its 2030 notes, realizing annual cash savings of USD 9.5 million and enhancing its capital structure.
  • The Board rejected an unsolicited nonbinding proposal from Parex, citing undervaluation and a commitment to maximizing shareholder value through strategic growth initiatives.
More info
Grifols, S.A. logo
GR
Grifols, S.A.
GRF.MC
Q3 2025
Reported:

Grifols delivered solid third-quarter performance with 7.7% revenue growth year-over-year, reflecting strong demand and effective cost management while facing external pressures.

Key takeaways
  • Year-to-date revenue reached EUR 5.5 billion, with a 10.5% increase on a like-for-like basis at constant currency.
  • Adjusted EBITDA for the third quarter was EUR 482 million, contributing to a total of EUR 1,358 million year-to-date, up 11.2% year-over-year.
  • Free cash flow improved significantly to EUR 188 million, marking a EUR 257 million increase versus the previous year.
  • Leverage ratio improved nearly 1x year-over-year to 4.2x, reflecting the company’s commitment to deleveraging.
  • Grifols remains on track to launch its fibrinogen therapy in Europe by late 2025 and is advancing strong clinical pipelines despite regulatory complexities.
More info
Knight Therapeutics Inc. logo
GU
Knight Therapeutics Inc.
GUD.TO
Q3 2025
Reported:

Knight Therapeutics reported its strongest financial results to date for Q3 2025, achieving record revenues of $122.6 million, driven by significant growth from its oncology portfolio and strategic acquisitions.

Key takeaways
  • Adjusted revenue rose 34% year-over-year, with a notable contribution of $25 million from the Paladin and Sumitomo portfolios.
  • Adjusted EBITDA reached $49 million for the first nine months of 2025, demonstrating robust operational efficiency.
  • Successful launches of three new products in key markets, including JORNAY PM in Canada and MINJUVI in Argentina, bolstered the revenue stream.
  • Despite setbacks with TAVALISSE and Qelbree regulatory submissions, the company remains committed to addressing regulatory requirements.
  • Knight initiated a Normal Course Issuer Bid (NCIB) to repurchase up to 3 million shares, enhancing shareholder value.
More info
Hyatt Hotels Corporation logo
H
Hyatt Hotels Corporation
H
Q3 2025
Reported:

Hyatt reported a modest 0.3% RevPAR growth for Q3 2025, driven by robust performance in luxury brands and leisure transient segments despite challenges from holiday shifts and tough year-over-year comparisons.

Key takeaways
  • System-wide RevPAR grew 0.3%, with luxury brands achieving 6% growth in leisure transient segments.
  • The company completed a sale of a Playa hotel for $22 million and remains on track to close transactions for 14 hotels by year-end.
  • Net rooms growth reached over 12%, supported by significant new openings including Hyatt Regency Times Square and Park Hyatt Kuala Lumpur.
  • Strong development pipeline of approximately 141,000 rooms, driven predominantly by upper mid-scale brand entries in untapped markets.
  • World of Hyatt loyalty program membership surged 20% year-over-year to over 61 million, highlighting the brand's growing appeal.
More info
Harvard Bioscience, Inc. logo
HB
Harvard Bioscience, Inc.
HBIO
Q3 2025
Reported:

Harvard Bioscience achieved strong operational advancements in Q3 2025, reporting revenues of $20.6 million and improved margins, while demonstrating robust customer engagement and a growing backlog ahead of the fourth quarter.

Key takeaways
  • Revenue of $20.6 million met guidance expectations, rebounding from a historically soft period.
  • Gross margin expanded to 58.4%, reflecting improved operational efficiency and a favorable product mix.
  • Customer order growth marked a year-over-year increase for the first time in over a year, driven by heightened demand and a growing product backlog.
  • Successful launch of the Incub8 Multiwell System bolstered market presence and initial customer feedback has been positive.
  • Strategic advances in capital structure highlight ongoing debt refinancing efforts, set for completion in Q4 2025.
More info
Henkel AG & Co. KGaA logo
HE
Henkel AG & Co. KGaA
HEN3.DE
Q3 2025
Reported:

Henkel delivered strong organic sales growth in Q3 2025, driven by robust performance across both business units, with particularly notable gains in North America and enhanced momentum in Adhesive Technologies.

Key takeaways
  • Both business units achieved positive organic sales growth, highlighting effective strategies and operational resilience.
  • The company remains on track with its share buyback program, executing approximately EUR 700 million by the end of October.
  • Adhesive Technologies is well-positioned to benefit from megatrends in sustainability and AI, with significant growth anticipated in Electronics Solutions through 2030.
More info
Heritage Insurance Holdings, Inc. logo
HR
Heritage Insurance Holdings, Inc.
HRTG
Q3 2025
Reported:

Heritage Insurance Holdings reported a robust third quarter, achieving a net income of $50.4 million, reflecting strong operational execution and strategic focus on rate adequacy and underwriting discipline.

Key takeaways
  • Net income surged by 120% year-over-year, with in-force premiums reaching a record $1.44 billion.
  • New business premium increased 166% year-over-year, indicating a rebound in growth after recent strategic adjustments.
  • Policy count reduction moderated significantly, marking the smallest decline since strategic initiatives were implemented in mid-2021.
  • Strong agency relationships and data-driven underwriting are expected to support future growth and enhance shareholder value.
  • Positive trends in reinsurance pricing and industry litigation environment bode well for the company’s financial outlook in 2026.
More info
International Consolidated Airlines Group, S.A. logo
IA
International Consolidated Airlines Group, S.A.
IAG.MC
Q3 2025
Reported:

International Airlines Group (IAG) reported a solid Q3 2025, with a 2% increase in passenger revenue and strong operational margins at 22%, driven by robust travel demand and effective cost management.

Key takeaways
  • Operating profit up EUR 40 million YoY, aided by solid performances from Iberia and Aer Lingus.
  • Margins across all airlines exceeded 20%, with Iberia achieving a 23.7% margin.
  • Non-fuel costs improved quarter-on-quarter, despite growing employee pay commitments; IAG remains focused on maintaining competitive cost controls.
  • Plans to return excess cash to shareholders are underway, signaling confidence in ongoing value creation and balance sheet strength.
  • Anticipating stable demand in the long-haul market; Q4 revenue outlook remains positive despite currency headwinds.
More info
iA Financial Corporation Inc. logo
IA
iA Financial Corporation Inc.
IAG.TO
Q3 2025
Reported:

iA Financial Group reported strong Q3 2025 results with core EPS rising 18% year-over-year to $3.47, driven by robust sales and the successful acquisition of RF Capital Group.

Key takeaways
  • Core ROE reached 17.2%, surpassing the 2027 target of 17%.
  • Total premiums and deposits grew by 6% year-over-year, with assets under management up 15%.
  • The acquisition of RF Capital is expected to strategically enhance iA's market position despite a pro forma solvency ratio adjustment to 135%.
  • Individual insurance sales remained robust with net premiums increasing by 11%, and Dealer Services sales grew by 9%.
  • U.S. individual insurance sales saw a significant 15% rise, outperforming Canadian sales for the quarter.
More info
International Consolidated Airlines Group, S.A. logo
IC
International Consolidated Airlines Group, S.A.
ICAGY
Q3 2025
Reported:

International Airlines Group (IAG) reported a solid third quarter in 2025, with stable passenger revenues and high operating margins, maintaining strong demand for travel while managing costs effectively.

Key takeaways
  • Operating margin reached 22% for the quarter, with all airlines reporting margins over 20%.
  • Revenue increased by EUR 177 million (2% year-on-year), driven primarily by robust travel demand.
  • Iberia led operating profit growth, up EUR 56 million to EUR 510 million, with a margin of 23.7%.
  • Nonfuel costs improved, partially offsetting higher operational expenses due to pay deals and new aircraft.
  • The outlook for Q4 remains positive, although projected currency headwinds may impact revenue performance.
More info
Intact Financial Corporation logo
IF
Intact Financial Corporation
IFC.TO
Q3 2025
Reported:

Intact Financial Corporation delivered strong Q3 2025 results, achieving a net operating income per share of $4.46, driven by robust underwriting performance and market share gains across all business lines.

Key takeaways
  • Top line growth of 6% complemented by a sub-90 combined ratio indicates solid margin management and operational efficiency.
  • The operating return on equity increased by 4 points to 20%, showcasing improved profitability across all regions.
  • Continued strong performance in Personal Lines and a 3% premium growth in Commercial Lines highlight successful growth initiatives, despite challenging market conditions in certain segments.
  • Strategic investments in AI are delivering over $150 million in annual recurring benefits, enhancing pricing and underwriting capabilities.
  • Plans for further market penetration in the UK and U.S. position the company well for sustained growth moving forward.
More info
International Seaways, Inc. logo
IN
International Seaways, Inc.
INSW
Q3 2025
Reported:

International Seaways reported a strong Q3 2025 with net income of $71 million, driven by effective fleet management and a commitment to returning capital to shareholders.

Key takeaways
  • Adjusted net income stood at $57 million ($1.15 per diluted share) with adjusted EBITDA of $108 million.
  • The company announced a combined dividend of $0.86 per share, marking its fifth consecutive quarter with a payout ratio exceeding 75%.
  • Two new LR1 vessels were delivered during the quarter, financed through an $82 million facility, contributing to fleet modernization.
  • The sale of five older vessels generated $67 million, with plans to sell three more in Q4 for an additional $37 million.
  • Robust liquidity position with total liquidity of $985 million and a low net loan-to-value ratio of 13%.
More info
Inuvo, Inc. logo
IN
Inuvo, Inc.
INUV
Q3 2025
Reported:

Inuvo, Inc. reported Q3 2025 revenues of $22.6 million, remaining flat year-over-year, but showcased strong year-to-date growth of 25% as the company adapts its strategy to meet client compliance needs.

Key takeaways
  • Q3 revenues were impacted by a strategic reduction in advertising spend in response to new client requirements; however, October saw a rebound in revenue.
  • The firm secured key client contracts anticipated to drive 65% growth from top clients by the end of 2025.
  • Inuvo expects a significant financial benefit from a settled class action lawsuit, with payouts anticipated in Q1 2026.
  • The appointment of COO Rob Buchner enhances business development efforts, particularly in pursuing high-value enterprise contracts.
  • Overall, Inuvo remains optimistic about meeting its revenue goals for 2025, with a focus on scalable growth initiatives going forward.
More info
Jazz Pharmaceuticals plc logo
JA
Jazz Pharmaceuticals plc
JAZZ
Q3 2025
Reported:

Jazz Pharmaceuticals achieved record revenues of over $1.1 billion in Q3 2025, fueled by strong sales across its product portfolio and two significant FDA approvals, paving the way for continued growth and strategic advancements.

Key takeaways
  • Secured FDA approvals for Modeyso and Zepzelca, expanding treatment options for severe conditions.
  • Strong commercial performance driven by Xywav's 11% year-over-year growth, contributing $431 million in net sales.
  • Narrowed 2025 revenue guidance to $4.175 billion - $4.275 billion, reflecting confidence in future performance.
  • Completed settlements in Xyrem antitrust litigation, allowing focus on strategic execution and shareholder value.
  • Strengthened the pipeline with the Saniona licensing agreement for a promising epilepsy candidate, SAN2355.
More info
Janus International Group, Inc. logo
JB
Janus International Group, Inc.
JBI
Q3 2025
Reported:

Janus International Group reported third-quarter 2025 revenue of $219.3 million, reflecting a 4.7% year-over-year decline, though adjusted EBITDA rose 1.2% to $43.6 million, highlighting resilience amid challenging market conditions.

Key takeaways
  • Self-storage revenue increased by 3.7%, supported by strong international growth despite North American softening.
  • Commercial and Other segment revenues decreased 20.1%, largely due to TMC project timing and LTL trucking industry weakness.
  • Adoption of Noke Smart Entry system grows significantly, with 439,000 units installed, up 35.9% year-over-year.
  • Continued investment in product innovation, including the launch of a new metal decking line and enhancements to the Noke platform.
  • Share repurchase program persists, with focus on M&A opportunities to leverage robust cash flow generation.
More info
Joby Aviation Inc. Common Stock logo
JO
Joby Aviation Inc. Common Stock
JOBY
Q3 2025
Reported:

Joby Aviation achieved a pivotal milestone in its certification journey by commencing power-on testing for its first aircraft intended for Type Inspection Authorization (TIA), showing strong operational performance amid increasing production capacity.

Key takeaways
  • Initiated power-on testing for TIA, representing a critical step in the FAA certification process.
  • Demonstrated operational capabilities with multiple successful flights, including a notable mission during the California International Air Show.
  • Engaged in the eIPP program discussions, positioning the company to leverage early demand for eVTOL operations ahead of full certification.
  • Expanded production significantly, producing 15x more FAA-conforming parts in 2025 compared to all of 2024, including new propeller blade manufacturing in Ohio.
  • Ongoing job creation in the manufacturing sector, with over 100 new roles added in Q3.
More info
Kennedy-Wilson Holdings, Inc. logo
KW
Kennedy-Wilson Holdings, Inc.
KW
Q3 2025
Reported:

Kennedy-Wilson reported strong Q3 2025 results with significant growth in adjusted EBITDA and a successful expansion of its investment management platform, highlighted by a notable increase in assets under management.

Key takeaways
  • Adjusted EBITDA rose to $125 million, nearly doubling from $66 million in Q3 2024; year-to-date adjusted EBITDA increased 6% to $371 million.
  • Assets under management reached $31 billion, an 11% year-over-year increase, while fee-bearing capital grew by 10% to $9.7 billion.
  • The company deployed approximately $900 million in Q3, contributing to a total of $3.5 billion year-to-date, with a focus on rental housing investments.
  • Kennedy-Wilson achieved $470 million in cash from asset sales year-to-date, surpassing its target of $400 million for the year.
  • A pending acquisition of Toll Brothers Apartment Living is set to significantly enhance its investment management platform, adding $5 billion in assets and scaling total AUM to approximately $36 billion.
More info
Lamar Advertising Company (REIT) logo
LA
Lamar Advertising Company (REIT)
LAMR
Q3 2025
Reported:

Lamar delivered resilient Q3 2025 results with a 2.9% year-over-year revenue growth, driven by strength in national/programmatic advertising and digital billboards, despite ongoing macroeconomic challenges.

Key takeaways
  • Acquisition-adjusted operating expenses rose 3.7%, primarily due to severance costs and technology implementation, but remained within revised guidance.
  • Adjusted EBITDA increased 3.5% year-over-year to $280.8 million, maintaining a strong adjusted EBITDA margin of 48%.
  • Successful capital transactions included raising $1.1 billion, enhancing the company’s already strong balance sheet and liquidity position.
  • Digital billboard revenue grew by 5%, representing 31% of total billboard billing, as Lamar continues to enhance its digital offerings.
  • Encouraging conversations with customers about 2026 indicate potential for strong growth, despite Q4 2025 likely facing challenges from political advertising.
More info
Gladstone Land Corporation logo
LA
Gladstone Land Corporation
LAND
Q3 2025
Reported:

Gladstone Land Corporation demonstrated prudent asset management in Q3, achieving a significant property sale and adjusting lease structures to optimize revenue amid challenging market conditions.

Key takeaways
  • Completed the sale of two farms in Florida for $21.5 million, generating a $6 million gain and a 36% premium over the original purchase price.
  • Adjusted the lease structures on six permanent crop properties to lower tenant costs and share in revenue growth, indicating flexible asset management.
  • Anticipates approximately $17 million in fourth-quarter revenue from recent harvests of almonds, pistachios, and grapes, signaling strong production levels.
  • Executed two lease renewals post-quarter, projecting a 7% increase in annual NOI.
  • Evaluating additional farm sales and lease transitions to enhance cash flow strategies and mitigate risks associated with high interest rates.
More info
Lantheus Holdings, Inc. logo
LN
Lantheus Holdings, Inc.
LNTH
Q3 2025
Reported:

Lantheus reported a solid third quarter in 2025, showcasing resilience in its core PSMA PET franchise despite a slight dip in sales, alongside strategic leadership transitions and preparations for the upcoming F-18 PET formulation launch.

Key takeaways
  • Q3 sales for PYLARIFY reached $240.6 million, reflecting a year-over-year decrease of 7%, but U.S. volumes showed a positive 3.3% increase.
  • The company announced a leadership transition with Mary Anne Heino stepping in as interim CEO post Brian Markison's retirement, ensuring continuity in strategic execution.
  • Lantheus is preparing for the expected launch of the new F-18 PSMA PET formulation in 2026, which aims to enhance production efficiency and patient access.
  • DEFINITY maintained a strong performance with over 6% year-over-year growth, underscoring its market leadership in ultrasound-enhancing agents.
  • The neurology franchise, especially Neuraceq, is positioned for growth driven by increasing demand in the Alzheimer's disease imaging market.
More info
Grand Canyon Education, Inc. logo
LO
Grand Canyon Education, Inc.
LOPE
Q3 2025
Reported:

Grand Canyon Education delivered robust growth in the third quarter of 2025, characterized by a 9.6% increase in online enrollment and a strong performance in hybrid programs, despite slight declines in traditional campus enrollment.

Key takeaways
  • Online campus new starts rose mid-single digits, totaling 9.6% enrollment growth, aligning with long-term strategic objectives.
  • Hybrid campus enrollments surged 17.4% year-over-year, driven by the introduction of affordable online prerequisite courses.
  • Traditional ground campus enrollment remained flat due to prior year challenges, but early indicators for fall 2026 suggest positive recruitment momentum.
  • Strategic partnerships with over 5,500 employers continue to support curriculum relevance and retention, enhancing GCU’s competitive position.
  • Strong demand for healthcare programs, particularly in nursing, positions GCU well amidst rising interest among younger students.
More info
Legrand SA logo
LR
Legrand SA
LR.PA
Q3 2025
Reported:

Legrand achieved robust growth in sales with a 14.5% increase year-to-date, supported by strong performance in data centers and strategic acquisitions, while maintaining solid profitability margins.

Key takeaways
  • Sales increased 14.5% excluding FX, with organic growth of 8.2%, primarily driven by a 30% rise in data center revenues.
  • Adjusted operating margin improved to 20.7%, up 20 bps year-on-year, reflecting robust operational execution and adaptation to market conditions.
  • Announced seven acquisitions to enhance presence in energy and digital sectors, with a total annualized sales contribution of approximately EUR 500 million.
  • Free cash flow increased by 16.3% to EUR 871 million, indicating strong cash generation capabilities.
  • Full-year guidance reaffirms growth targets of 10% to 12% and operating margin of 20.5% to 21%, aligning with previous forecasts.
More info
Lyft, Inc. logo
LY
Lyft, Inc.
LYFT
Q3 2025
Reported:

Lyft posted a record third quarter with significant growth in active riders, gross bookings, and adjusted EBITDA, alongside its first-ever $1 billion free cash flow generation.

Key takeaways
  • Active riders grew 18% year-over-year, achieving an all-time high, with gross bookings up 16%.
  • Adjusted EBITDA increased by 29%, reflecting strong operational efficiency and profit potential.
  • Strategic partnership with United Airlines now live, enhancing customer incentives and expanding growth avenues.
  • Anticipated continued growth momentum in Q4, with rides projected to increase mid- to high teens and gross bookings up 17% to 20%.
  • Ongoing advancements in autonomous vehicle partnerships and underpenetrated market opportunities expected to drive performance into 2026.
More info
MetLife, Inc. logo
ME
MetLife, Inc.
MET
Q3 2025
Reported:

MetLife delivered strong third-quarter results, with adjusted earnings rising 22% year-over-year to $1.6 billion, driven by robust investment margins and operational efficiencies.

Key takeaways
  • Adjusted earnings reached $1.6 billion or $2.34 per share, exceeding expectations with strong contributions from variable investment income and volume growth.
  • Group Benefits segment reported a 6% increase in adjusted earnings, supported by improved disability and dental profitability.
  • Adjusted earnings from Asia surged 36%, bolstered by a 34% rise in sales, particularly strong in Japan.
  • MetLife's new Accelerator platform in Latin America has secured over 20 partners, generating $340 million in annualized premiums since launch.
  • Adjusted return on equity reached 16.7%, aligning with the company's targets and showcasing the effectiveness of the New Frontier strategy.
More info
Mistras Group, Inc. logo
MG
Mistras Group, Inc.
MG
Q3 2025
Reported:

MISTRAS Group reported robust Q3 2025 results, achieving a 7% year-over-year revenue growth driven by strong performance across all major end markets, with record adjusted EBITDA highlighting improved operating leverage.

Key takeaways
  • Consolidated revenue reached $85.4 million, with net income of $13.1 million and earnings per diluted share of $0.41.
  • Gross profit increased by 19% year-over-year, resulting in a gross margin expansion of 300 basis points to 29.8%.
  • Notable growth in the energy sector at 8.1%, particularly from power generation services, boosted by demand for renewable offerings.
  • Strategic initiatives included enhancing offerings and diversifying client bases, exemplified by new projects with Batchelor & Kimball and Bechtel.
  • Record quarterly adjusted EBITDA stood at $30.2 million, reflecting a 29.6% increase from the prior year, underscoring improved operational efficiencies.
More info
Melco Resorts & Entertainment Limited logo
ML
Melco Resorts & Entertainment Limited
MLCO
Q3 2025
Reported:

Melco Resorts & Entertainment reported strong Q3 2025 performance with group-wide adjusted property EBITDA rising 18% year-over-year to approximately $380 million, driven by robust recovery in Macau and significant growth in the Philippines and Cyprus.

Key takeaways
  • Macau property EBITDA increased by 21% year-over-year, achieving record mass table GGR in October.
  • Strong momentum in the Philippines with 45% quarter-over-quarter EBITDA growth; Cyprus property EBITDA rose 53% year-over-year.
  • Liquidity remains strong at $2.6 billion, with a cash balance increase of $360 million, facilitating ongoing debt repayments.
  • Introduction of new premium offerings, including the Signature Clubhouse at City of Dreams, enhancing customer engagement.
  • Continued operational discipline maintained with steady OpEx at approximately $3 million per day.
More info
Miller Industries, Inc. logo
ML
Miller Industries, Inc.
MLR
Q3 2025
Reported:

Miller Industries reported a challenging third quarter in 2025 with a significant drop in net sales, primarily due to decreased chassis shipments, yet implemented strategic measures to enhance operational efficiency and cash flow.

Key takeaways
  • Net sales fell 43.1% year-over-year to $178.7 million, driven by reduced chassis shipments.
  • Gross profit margin improved to 14.2%, aided by a favorable product mix.
  • Cash balance increased by $6.6 million sequentially to $38.4 million, reflecting effective cash management and inventory adjustments.
  • Debt reduced by $10 million to $45 million during the quarter, with a further reduction to $35 million post-Q3.
  • Strategic production adjustments aimed at normalizing inventory levels are anticipated to position the company favorably for recovery in 2026.
More info
Maravai LifeSciences Holdings, Inc. logo
MR
Maravai LifeSciences Holdings, Inc.
MRVI
Q3 2025
Reported:

Maravai LifeSciences reported Q3 2025 total revenues of $41.6 million, marked by a 7% growth in Biologic Safety Testing, but a significant 53% decline in Nucleic Acid Products year-over-year. Cost restructuring efforts are on track, aiming for positive adjusted EBITDA by 2026.

Key takeaways
  • Biologic Safety Testing revenue reached $16.3 million, benefiting from strong demand in core markets, particularly in the Americas and Europe.
  • Nucleic Acid Products saw a 53% revenue decline, largely due to COVID-related order timing, though growth is anticipated in Q4.
  • Management expects an annualized expense reduction exceeding $50 million and projects over $7 million in sequential adjusted EBITDA improvement in Q4.
  • New product innovations like ModTail technology and IVT kits are gaining traction and could significantly enhance revenue streams moving forward.
  • Cygnus remains a leader in the Biologic Safety Testing space, maintaining 100% market coverage in CAR-T and gene therapy products.
More info
Marex Group plc Ordinary Shares logo
MR
Marex Group plc Ordinary Shares
MRX
Q3 2025
Reported:

Marex achieved robust Q3 2025 results with a 25% year-on-year increase in adjusted profit before tax to $101 million, driven by strong performance in its Clearing and Prime Services segments despite challenging market conditions.

Key takeaways
  • Adjusted profit before tax for the first nine months of 2025 reached $303 million, up 26% year-on-year.
  • Q3 revenues increased 24% to $485 million, enhancing margins to 20.9%.
  • The Clearing segment saw a 4% quarter-over-quarter increase in average client balances, bolstered by strong client onboarding.
  • Prime Services generated $171 million in revenue in the first nine months after acquisition, now representing nearly 25% of total profits.
  • The company is pursuing M&A opportunities to further diversify and enhance growth, including the recent acquisition of Winterflood.
More info
National Australia Bank Limited logo
NA
National Australia Bank Limited
NAB.AX
Q4 2025
Reported:

National Australia Bank (NAB) reported stable cash earnings for FY2025, supported by a 5.8% growth in business lending and a positive revenue trajectory despite higher impairment charges.

Key takeaways
  • Cash earnings were stable year-over-year, with a total dividend of $1.70 for FY2025, maintaining a payout ratio of 73.3%.
  • Revenue increased by 2.9%, driven by strong volume growth and improved market conditions in business credit.
  • NAB's common equity Tier 1 capital ratio stood at 11.7%, comfortably meeting targets while maintaining robust provisioning levels.
  • The bank's strategic focus on customer advocacy is yielding tangible improvements, with 12 out of 20 priority areas showing enhanced outcomes.
  • NAB's position as the top business lender in Australia highlights its effective balance sheet management and market growth strategies.
More info
Nature's Sunshine Products, Inc. logo
NA
Nature's Sunshine Products, Inc.
NATR
Q3 2025
Reported:

Nature's Sunshine achieved record third-quarter net sales of $128.3 million, reflecting a robust 12% year-over-year growth driven by strategic investments and strong execution across key markets.

Key takeaways
  • Record net sales in Q3 2025 reached $128.3 million, up from $114.6 million in the same period last year.
  • Significant digital sales growth of 52% year-over-year, with new digital customer purchases more than doubling.
  • Over half of direct-to-consumer orders now come from subscription auto ship programs, enhancing customer retention and revenue predictability.
  • Strong performance across regions, particularly in North America and Asia Pacific, indicating effective transformation initiatives.
  • Continued focus on digital capabilities, cost management, and field engagement sets the stage for sustained profitable expansion.
More info
Novo Nordisk A/S logo
NO
Novo Nordisk A/S
NOVO-B.CO
Q3 2025
Reported:

Novo Nordisk reported robust Q3 2025 results, achieving 15% sales growth and 10% operating profit growth, while narrowing guidance due to anticipated lower growth in GLP-1 diabetes and obesity treatments.

Key takeaways
  • Approved Rybelsus with cardiovascular indications in the U.S. and EU, enhancing portfolio in diabetes care.
  • Obesity care sales surged 41%, significantly boosted by a 168% increase in Wegovy, underscoring strong demand.
  • Initiated a company-wide transformation expected to lead to DKK 8 billion in annual savings by 2026, focusing resources on diabetes and obesity.
  • Operational efficiency improvements are anticipated from the reduction of approximately 9,000 global positions, aiming to enhance shareholder returns.
More info
Nerdy Inc. Class A Common Stock logo
NR
Nerdy Inc. Class A Common Stock
NRDY
Q3 2025
Reported:

Nerdy, Inc. faced challenges in Q3 2025 due to delays in product launches and technical debt impacting growth, but made significant strides in replatforming its core systems leveraging AI, positioning the company for improved performance moving forward.

Key takeaways
  • Product launch delays during the back-to-school season hindered expected growth and profitability.
  • Significant progress in transitioning to AI-assisted software development, aiming for nearly 100% new code base by November.
  • New features, including a unified student-tutor interface and the AI Practice Hub, are driving improved user engagement and retention.
  • Early indications show a 50% increase in consumption of self-study tools and positive trends in tutor quality through enhanced vetting processes.
  • Focus for Q4 includes enhancing customer discovery and onboarding with gamification and other innovative features.
More info
NRG Energy, Inc. logo
NR
NRG Energy, Inc.
NRG
Q3 2025
Reported:

NRG Energy reported a robust third quarter with adjusted EPS rising 32% year-over-year and confirmed a $100 million increase in 2025 financial guidance, driven by strong performance across Energy and Smart Home segments.

Key takeaways
  • Adjusted EBITDA reached a record high, reflecting successful margin improvements and operational efficiencies.
  • Expanded data center power agreements to a total of 445 megawatts, with new pricing targets raised above $80 per megawatt hour.
  • LS Power acquisition is on track for a first quarter 2026 close, enhancing NRG's competitive positioning and projected 14% EPS CAGR through 2029.
  • Year-to-date adjusted EPS is up 36%, supporting the company's long-term growth targets.
More info
Intellia Therapeutics, Inc. logo
NT
Intellia Therapeutics, Inc.
NTLA
Q3 2025
Reported:

Intellia Therapeutics faced significant challenges in Q3 2025, including a clinical hold on its nex-z program following serious safety concerns, while making substantial progress in its lonvo-z development for hereditary angioedema.

Key takeaways
  • The FDA imposed a clinical hold on both the MAGNITUDE and MAGNITUDE-2 trials of nex-z due to safety issues, including increased liver enzyme levels in a patient who later passed away.
  • Enrollment for the Phase III trial of lonvo-z was completed ahead of schedule, with top-line data expected by mid-2026 and a potential U.S. launch in early 2027.
  • Intellia's cash position remains strong at $669.9 million, bolstered by a $115 million capital raise, extending its cash runway into mid-2027.
  • Collaboration revenue climbed to $13.8 million, primarily due to cost reimbursements from Regeneron Pharmaceuticals, reflecting active partnerships.
  • R&D expenses decreased to $94.7 million, driven by cost-cutting measures, highlighting the company's focus on managing operational expenditures amidst program uncertainties.
More info
Natera, Inc. logo
NT
Natera, Inc.
NTRA
Q3 2025
Reported:

Natera reported robust Q3 2025 results, with revenue growth of 35% year-over-year driven by strong demand for its clinical products, particularly Signatera, alongside a notable improvement in gross margins.

Key takeaways
  • Revenue for the quarter reached $592 million, significantly exceeding last year’s performance.
  • Clinical MRD tests exceeded 202,000, marking record growth with 21,500 additional units.
  • Gross margins surged to 64.9%, reflecting efficiency gains and cost management.
  • The company raised its 2025 revenue guidance by $160 million, now forecasting $2.18–$2.26 billion.
  • Expanding the product offering with the new Fetal Focus test, targeting over 20 genes with positive initial feedback.
More info
Nova Measuring Instruments Ltd. logo
NV
Nova Measuring Instruments Ltd.
NVMI
Q3 2025
Reported:

Nova reported record quarterly revenue of $224.6 million in Q3 2025, achieving 25% year-over-year growth driven by strong demand across advanced nodes and packaging solutions.

Key takeaways
  • Record sales in memory driven by strong demand for advanced DRAM and high-bandwidth memory solutions.
  • Advanced logic revenue surged with major orders for the ELIPSON materials metrology platform validated for high-volume production.
  • Significant expansion in advanced packaging solutions, highlighted by the successful launch and adoption of the Nova WMC platform.
  • New production facility in Mannheim, Germany, opened to triple capacity for advanced packaging optical metrology solutions.
  • 2025 guidance indicates continued growth trajectory, expected to reach approximately 30% year-over-year at the midpoint.
More info
Novo Nordisk A/S logo
NV
Novo Nordisk A/S
NVO
Q3 2025
Reported:

Novo Nordisk reported strong Q3 2025 results with a 15% increase in sales and 10% rise in operating profit, while narrowing its sales and operating profit guidance due to projected slower growth in its GLP-1 treatments.

Key takeaways
  • Sales growth was driven by both U.S. (15%) and international operations (16%), bolstered by one-off adjustments in the U.S. of DKK 6 billion.
  • Obesity care surged 41%, led by a 24% growth in U.S. sales and an impressive 83% growth internationally.
  • The company is executing a strategic transformation involving a reduction of approximately 9,000 global positions, expected to yield annual savings of DKK 8 billion by 2026.
  • Rybelsus received regulatory approval in the U.S. and EU, enhancing Novo's offerings in diabetes care.
  • Ongoing focus on diabetes and obesity, coupled with portfolio refinement, reaffirms Novo Nordisk's commitment to addressing major unmet medical needs.
More info
Universal Display Corporation logo
OL
Universal Display Corporation
OLED
Q3 2025
Reported:

Universal Display Corporation reported Q3 2025 revenues of $140 million, reflecting a year-over-year decline, primarily due to timing dynamics in customer orders, while investments in R&D and strategic acquisitions signal a commitment to future growth.

Key takeaways
  • Revenue declined to $140 million compared to $162 million in Q3 2024 and $478 million year-to-date, with a full-year estimate expected at the lower end of $650 million to $700 million.
  • The company announced plans to acquire OLED patent assets from Merck KGaA for $50 million, enhancing its R&D capabilities for next-generation OLED technologies.
  • Royalty and licensing revenue fell to $53 million, adversely impacted by a one-time adjustment of $9.5 million.
  • Green emitter sales showed growth at $65 million while red emitter sales decreased to $17 million.
  • Future growth anticipated as rising OLED adoption drives expansion, with significant new manufacturing capacity expected to come online in 2026.
More info
Olaplex Holdings Inc. Common Stock logo
OL
Olaplex Holdings Inc. Common Stock
OLPX
Q3 2025
Reported:

Olaplex Holdings reported third-quarter fiscal 2025 results that slightly exceeded expectations, demonstrating early signs of improvement in brand performance and effective execution of strategic initiatives.

Key takeaways
  • Net sales were $114.6 million, down 3.8% year-over-year, but better than anticipated due to early shipment timing.
  • Adjusted EBITDA reached $30.8 million with a margin of 26.9%, benefiting from robust sales flow-through.
  • Significant marketing investments are yielding positive brand perception shifts, enhancing emotional connection and consumer engagement.
  • A successful launch of two new hair masks marked the company's most integrated product introduction, featuring a comprehensive 360-degree marketing campaign.
  • Sales trends showed improvement in professional channels, signaling recovery and growth potential in previously reset markets.
More info
Onity Group Inc. logo
ON
Onity Group Inc.
ONIT
Q3 2025
Reported:

Onity Group reported robust third-quarter performance, bolstered by record origination volumes and strong servicing profitability, resulting in increased adjusted pretax income and return on equity.

Key takeaways
  • Adjusted pretax income reached $31 million with an annualized return on equity of 25%, exceeding guidance.
  • GAAP net income reported at $2.03 per share, inclusive of a $0.48 tax provision linked to strategic planning.
  • Year-over-year servicing portfolio growth of 6%, driven by $39 billion in servicing additions, outpacing planned transfers and sales.
  • Originations volume surged 39% compared to last year, marking the highest funded volume recorded with a market size considerably lower than the 2021 peak.
  • Continuous investment in technology and optimization strategies is enhancing customer experience and operational efficiency across channels.
More info
OptimizeRx Corporation logo
OP
OptimizeRx Corporation
OPRX
Q3 2025
Reported:

OptimizeRx reported a robust Q3 2025 with revenues of $26.1 million, reflecting a 22% year-over-year growth, and an adjusted EBITDA of $5.1 million, exceeding expectations.

Key takeaways
  • Revenue guidance for FY 2025 has been raised to $105-$109 million, with adjusted EBITDA now expected between $16-$19 million.
  • Average revenue from the top 5 customers has grown beyond $11 million, demonstrating strong client relationships and engagement.
  • The company continues to reduce its debt, paying down an additional $2 million, and does not anticipate needing to access equity capital markets in the near future.
  • Gross margin improved to 67.2%, driven by a favorable product and channel mix, alongside disciplined cost management efforts.
  • Initial guidance for FY 2026 indicates revenue of $118-$124 million and adjusted EBITDA of $19-$22 million, signaling confidence in future growth.
More info
Oscar Health, Inc. logo
OS
Oscar Health, Inc.
OSCR
Q3 2025
Reported:

Oscar Health reported a 23% year-over-year increase in revenue for Q3 2025, although losses widened due to higher market morbidity. The company remains optimistic about profitability improvements in 2026.

Key takeaways
  • Total revenue reached approximately $3 billion, with an adjusted EBITDA loss of $101 million.
  • Membership increased by 28% year-over-year, surpassing 2 million members.
  • The company implemented a disciplined pricing strategy for 2026, with a weighted average rate increase of about 28%.
  • New innovative products, including HelloMeno, are designed to capture additional market share and cater to women's health.
  • Oscar is integrating an AI health agent, Oswell, across its product offerings to enhance member engagement and support.
More info
PDF Solutions, Inc. logo
PD
PDF Solutions, Inc.
PDFS
Q3 2025
Reported:

PDF Solutions, Inc. reported strong third-quarter performance, driven by robust bookings and strategic technology partnerships that bolster their position in AI-driven analytics within the semiconductor industry.

Key takeaways
  • Secured multiple 8-figure contracts, including agreements to expand AI analytics capabilities with a large IC manufacturer and a prominent equipment OEM.
  • Integrated Tiber AI Studio into Exensio, enhancing AI model management and deployment, addressing customers' needs for efficient scaling of AI applications.
  • Strong revenue contributions from Cimetrix connectivity software, marking the highest performance since its acquisition, positioning PDF as a leader in connectivity solutions.
  • Customer base has grown from 150 to over 370 since 2020, now encompassing major players in the equipment and cloud sectors.
  • Continued investments in product development and infrastructure are expected to enhance profitability and balance sheet strength by 2026.
More info
Penumbra, Inc. logo
PE
Penumbra, Inc.
PEN
Q3 2025
Reported:

Penumbra reported strong third-quarter results for 2025, achieving $354.7 million in revenue driven by robust growth across its U.S. thrombectomy and embolization franchises, highlighting its competitive positioning and successful product innovation.

Key takeaways
  • Total revenue increased by 17.8% year-over-year, with U.S. revenue growing 21.5% to $275 million.
  • The VTE franchise achieved remarkable 34% year-over-year growth, affirming its market leadership.
  • Gross margin expanded to 67.8%, with operating income at $48.8 million (13.8% of revenue), and future margins are projected to exceed 70%.
  • FDA clearance for breakthrough products Lightning Bolt 16 and Lightning Flash 3.0 enhances Penumbra's advanced CAVT device portfolio.
  • The integration of a dedicated embolization sales team has resulted in a 21.2% sequential revenue increase in this segment.
More info
Pharming Group N.V. logo
PH
Pharming Group N.V.
PHARM.AS
Q3 2025
Reported:

Pharming Group N.V. achieved robust growth in Q3 2025, with total revenues increasing by 30% year-over-year to $82 million, driven by strong performance in its commercial products RUCONEST and Joenja.

Key takeaways
  • Operating profit surged nearly fourfold to $15.8 million, with operating cash flow reaching $32 million.
  • RUCONEST revenue grew 29%, benefiting from increased prescriber adoption and new patient enrollments.
  • Joenja saw a 35% revenue increase, supported by a 25% rise in U.S. patients on therapy and an expanding patient funnel.
  • The company raised its full-year 2025 revenue guidance to a range of $360 million to $375 million, reflecting ongoing commercial momentum.
  • Planned reductions in G&A headcount will optimize capital for high-growth initiatives, enhancing Pharming's competitive positioning in the rare disease market.
More info
Playtika Holding Corp. logo
PL
Playtika Holding Corp.
PLTK
Q3 2025
Reported:

Playtika reported a strong Q3 2025, driven by record direct-to-consumer revenue and exceptional performance from Disney Solitaire, although it faced challenges from a declining Slotomania.

Key takeaways
  • Total revenue reached $674.6 million, marking an 8.7% year-over-year increase despite a 3.1% sequential decline.
  • Direct-to-consumer revenue surpassed $209 million, up 19% sequentially and contributing 31% of total revenue.
  • Disney Solitaire is on track for a $200 million annualized run rate, the fastest scaling title in Playtika's history.
  • Slotomania revenue dropped 20.8% sequentially and 46.7% year-over-year as the company rebalanced the game economy.
  • Adjusted EBITDA rose 30.2% sequentially to $217.5 million, reflecting improved operating margins and disciplined marketing expenditure.
More info
Insulet Corporation logo
PO
Insulet Corporation
PODD
Q3 2025
Reported:

Insulet Corporation delivered a remarkable third quarter in 2025, achieving over $700 million in revenue, reflecting a 28% year-over-year growth, driven by strong customer retention and expansion in both Type 1 and Type 2 markets.

Key takeaways
  • Surpassed $700 million in quarterly revenue for the first time, demonstrating the strength of its recurring revenue model.
  • Operating margins increased by 90 basis points to 17.1%, reflecting efficient cost management alongside investments in innovation.
  • New customer starts in the U.S. Type 2 market more than doubled year-over-year, highlighting strong momentum and effective outreach strategies.
  • International revenue grew 40% year-over-year, driven by successful global launches, including Omnipod 5, and strong demand in established markets.
  • The expanded leadership team aims to further enhance Insulet's market position and customer experience across various segments.
More info
Primo Brands Corporation logo
PR
Primo Brands Corporation
PRMB
Q3 2025
Reported:

Primo Brands Corporation reported a resilient Q3 2025 performance with net sales reaching $1.766 billion, reflecting a slight year-over-year decline but improved operational efficiency leading to significant adjusted EBITDA growth.

Key takeaways
  • Net sales declined 1.6% year-over-year, but improved from a 2.5% decline in Q2 2025, showcasing customer retention efforts.
  • Adjusted EBITDA rose 6.8% to $404.5 million, resulting in a margin increase to 22.9%.
  • Delivery service rates recovered to 95% as integration challenges were addressed, supporting future growth potential.
  • The company remains on track to achieve synergy targets of $200 million by the end of 2025 and $300 million by 2026.
  • Eric Foss has been appointed as Chairman and CEO, expected to drive brand growth and operational excellence moving forward.
More info
Priority Technology Holdings, Inc. logo
PR
Priority Technology Holdings, Inc.
PRTH
Q3 2025
Reported:

Priority Technology Holdings demonstrated solid growth in Q3 2025, with net revenue increasing by 6% and adjusted EPS rising 56% year-over-year.

Key takeaways
  • Revenue reached $241.4 million, driven by strong performance in Payables and Treasury Solutions, which saw 14% and 18% growth, respectively.
  • Adjusted gross profit margin improved to 39.2%, reflecting the ongoing success in high-margin segments despite moderated growth in Merchant Solutions.
  • The company revised its full-year revenue guidance to a range of $950 million to $965 million, anticipating growth of 8% to 10%, while raising adjusted gross profit guidance to $370 million at the low end.
More info
Privia Health Group, Inc. logo
PR
Privia Health Group, Inc.
PRVA
Q3 2025
Reported:

Privia Health reported robust third-quarter results, marked by significant growth in practice collections and adjusted EBITDA, leading to an upward revision of its 2025 financial guidance.

Key takeaways
  • Implemented provider growth of 13.1% year-over-year, reaching 5,250, driving practice collections up 27.1% to $940.4 million.
  • Adjusted EBITDA surged 61.6%, expanding the EBITDA margin to 30.5%, a 720 basis point improvement from the prior year.
  • Increased total attributed lives by nearly 13% year-over-year, with plans to further expand through the acquisition of an ACO business from Evolent Health, enhancing market presence and value-based services.
More info
PSQ Holdings, Inc. logo
PS
PSQ Holdings, Inc.
PSQH
Q3 2025
Reported:

PublicSquare reported a strong performance in Q3 2025, exceeding revenue guidance by 10% with a notable year-over-year revenue growth of 37%, driven primarily by its expanding fintech division.

Key takeaways
  • Fintech revenue surged by 28% quarter-over-quarter, with payments revenue up 50%.
  • Operating expenses decreased by 13% year-over-year, leading to a 33% reduction in net loss compared to the same period in 2024.
  • General and administrative expenses saw a significant drop of 22.3%, reflecting continued expense discipline and optimization strategies.
  • Improvements in underwriting practices contributed to enhanced credit portfolio performance, with a 22% quarter-over-quarter revenue increase from the credit business.
  • The company reaffirmed its revenue guidance for Q4 2025 and full year 2026, indicating confidence in sustained fintech growth.
More info
P10 Inc. Class A Common Stock logo
PX
P10 Inc. Class A Common Stock
PX
Q3 2025
Reported:

P10 delivered strong third-quarter results, raising $915 million in gross fee-paying assets under management, driving total AUM to $29.1 billion, a year-over-year increase of 17%. The company exceeded its fundraising guidance for 2025, raising its target to nearly $5 billion.

Key takeaways
  • Third quarter marked the successful raise and deployment of $915 million in new fee-paying AUM, showcasing robust capital commitments.
  • Year-to-date fee-related revenue increased by 5%, excluding catch-up fees, reflecting ongoing demand for P10's investment strategies.
  • Launch of four new funds and strong performance of Secondary Fund V, closing at $1.26 billion, highlights continued growth in P10's commingled fund business.
  • The company is well-positioned to capture opportunities in the middle and lower-middle markets, driven by secular demand trends.
  • P10 announced a dual listing on NYSE Texas, enhancing its engagement with the investment community.
More info
AVITA Medical, Inc. logo
RC
AVITA Medical, Inc.
RCEL
Q3 2025
Reported:

AVITA Medical reported Q3 2025 revenues of approximately $17 million, falling short of expectations due to ongoing reimbursement disruptions, but anticipates renewed demand and adoption for its RECELL product following resolution of payment clarity.

Key takeaways
  • Revenue guidance for the full year adjusted to $70 million to $74 million, down from $76 million to $81 million.
  • All seven regional Medicare Administrative Contractors have established reimbursement rates for RECELL, enhancing clinician confidence and adoption.
  • The company is refining its commercial strategies, focusing on approximately 200 key burn centers, representing a $1.3 billion opportunity within the broader $3.5 billion U.S. market.
  • Recent CE Mark approval for RECELL GO expands access to the technology in Europe, with the first patient treated in Germany.
  • Management's immediate priorities include revitalizing order momentum, driving consistent product utilization, and finalizing the transition of the commercial organization for improved performance.
More info
Redwire Corporation Common Stock logo
RD
Redwire Corporation Common Stock
RDW
Q3 2025
Reported:

Redwire Corporation reported impressive Q3 2025 results, with significant revenue growth and improved margins following its strategic acquisition of Edge Autonomy. However, potential delays in government contracts due to the ongoing U.S. government shutdown may impact short-term performance.

Key takeaways
  • Revenue surged 67.5% sequentially and 57% year-over-year, reaching $103.4 million.
  • Adjusted gross margin improved to 27.1%, with a $24.8 million increase in adjusted EBITDA.
  • Book-to-bill ratio of 1.25 resulted in a backlog of $355.6 million, driven by strong customer demand.
  • Near-term government contract delays are anticipated due to the ongoing shutdown, though long-term demand remains strong.
  • Redwire is positioned as a leader in next-gen space technologies, particularly in VLEO and GEO with key partnerships and contracts.
More info
Remitly Global Inc. Common Stock logo
RE
Remitly Global Inc. Common Stock
RELY
Q3 2025
Reported:

In Q3 2025, Remitly reported a robust 25% revenue growth alongside a 15% adjusted EBITDA margin, demonstrating strong operational execution and sustained investment in business expansion.

Key takeaways
  • Business segment growth accelerated with nearly 10,000 companies now using the platform, doubling send volume sequentially.
  • Reliability metrics improved significantly, achieving 99.99% uptime and facilitating rapid transaction completion—over 94% within an hour.
  • The expansion of send limits for U.S. customers to $100,000 has driven over 40% year-over-year volume growth among high-amount senders.
  • Continued strategic investments in customer-centric pricing and targeted marketing are enhancing Remitly's competitive positioning in the global payments market.
More info
Sturm, Ruger & Company, Inc. logo
RG
Sturm, Ruger & Company, Inc.
RGR
Q3 2025
Reported:

Sturm, Ruger & Company reported a modest year-over-year sales increase to $126.8 million for Q3 2025 amidst ongoing market challenges, while losses per share were significantly impacted by operational costs and strategic investments.

Key takeaways
  • Net sales increased by 3.7% year-over-year, but diluted earnings per share decreased to $0.10, primarily due to $1.9 million in costs from a newly acquired facility and heightened promotional expenses.
  • The company posted a pretax loss of $2.1 million, contrasted by $3 million in tax benefits that averted deeper losses.
  • Cash and short-term investments stand at $81 million with no debt, reflecting a strong balance sheet amid capital expenditures of $28 million year-to-date.
  • Shareholder returns included $13 million in Q3 via dividends and stock buybacks, with a declared dividend of $0.04 per share for Q3, representing roughly 40% of net income.
  • New product sales comprised 34% of net firearms sales, highlighting ongoing innovation despite a declining overall firearms market.
More info
Sunrun Inc. logo
RU
Sunrun Inc.
RUN
Q3 2025
Reported:

Sunrun delivered strong third-quarter results, achieving a 10% year-over-year growth in aggregate subscriber value, driven by a strategic focus on energy independence and customer-centric offerings.

Key takeaways
  • $1.6 billion in aggregate subscriber value, at the top end of guidance, with a 35% increase in contracted net value creation.
  • Generated $108 million in cash, marking the sixth consecutive quarter of positive cash generation and exceeding previous guidance.
  • Over 1.1 million customers served, with significant traction in innovative product offerings like Flex, boosting recurring cash flow.
  • Established a formidable power generation capacity with 3.7 gigawatt hours of dispatchable energy from home batteries and 8.2 gigawatts of solar capacity.
  • Anticipating rapid growth in cash flow as the company scales energy storage and solar offerings to meet increasing nationwide energy demands.
More info
Recursion Pharmaceuticals, Inc. logo
RX
Recursion Pharmaceuticals, Inc.
RXRX
Q3 2025
Reported:

Recursion's Q3 2025 earnings report reflects strong operational momentum, highlighted by a significant milestone payment from Roche and a sustained cash balance to support future initiatives under new CEO, Najat Khan.

Key takeaways
  • Transition of leadership with Najat Khan stepping in as CEO on January 1, signaling a bold new strategic focus for the company.
  • Achieved $30 million milestone payment from Roche, contributing to over $0.5 billion in total cash inflows from partnerships—a notable accomplishment for a pre-commercial biotech firm.
  • Robust cash position of nearly $800 million, providing operational runway through 2027 without additional financing, enabling the pursuit of multiple upcoming catalysts.
  • Continued advancements in the neuro map and microglial cell projects, critical for developing novel therapeutics in neuroscience and oncology.
More info
Rayonier Advanced Materials Inc. logo
RY
Rayonier Advanced Materials Inc.
RYAM
Q3 2025
Reported:

RYAM reported Q3 2025 earnings reflecting operational stabilization and strategic adjustments, resulting in refined full-year adjusted EBITDA guidance of $135 to $140 million.

Key takeaways
  • Adjusted EBITDA guidance for 2025 decreased due to proactive downtime in noncore production and weakened paperboard markets.
  • Continued success in Cellulose Specialties with normalized EBITDA margins, despite challenges in the fluff product segment due to tariffs impacting U.S. exports to China.
  • Operational challenges are being resolved, with key staffing roles filled to stabilize performance at the Tartas facility.
  • Strategic initiatives at the Temiscaming site aim to reduce costs and improve profitability, with new product developments underway expected to generate significant EBITDA contributions in 2026.
  • Trade conditions are improving for U.S. producers, with favorable developments in ongoing investigations regarding Brazilian and Norwegian imports, potentially leveling the competitive landscape.
More info
Sabre Corporation logo
SA
Sabre Corporation
SABR
Q3 2025
Reported:

Sabre's Q3 2025 results reflect solid operational performance with a 3% revenue growth and significant progress in air distribution bookings, driven by strategic initiatives and improving market conditions.

Key takeaways
  • Total distribution bookings increased 3% YoY, with air distribution bookings up over 2%, bolstered by a strong performance in September.
  • Normalized adjusted EBITDA grew 23%, leading to an improved margin of 21%, demonstrating effective expense management.
  • The company expects to reduce net leverage by approximately 50% by the end of 2025 compared to year-end 2023, showcasing continued focus on deleveraging.
  • Sabre introduced AI-driven enhancements, including agentic APIs and the Continuous Revenue Optimizer, enhancing its competitive positioning in the travel industry.
  • Hotel distribution bookings grew 6%, with substantial progress in new agency partnerships and NDC integrations.
More info
Sinclair Broadcast Group, Inc. logo
SB
Sinclair Broadcast Group, Inc.
SBGI
Q3 2025
Reported:

Sinclair Broadcast Group achieved robust third-quarter results, surpassing revenue and EBITDA guidance while advancing strategic station acquisitions amidst a favorable regulatory backdrop for industry consolidation.

Key takeaways
  • Total revenue reached $773 million, exceeding guidance, with core revenues up 7% year-over-year.
  • Adjusted EBITDA of $100 million surpassed expectations, reflecting effective cost management.
  • Significant progress in station acquisitions, with 11 closed and 12 pending FCC approval, projected to generate an incremental $30 million in annual adjusted EBITDA.
  • The regulatory environment is shifting favorably for consolidation, with potential for significant synergies in the broadcast sector.
  • Early indicators suggest record midterm political advertising revenue in 2026, likely matching or exceeding the $333 million achieved in 2022.
More info
Seadrill Limited logo
SD
Seadrill Limited
SDRL
Q3 2025
Reported:

Seadrill's Q3 2025 earnings reflect strong operational performance and strategic contract wins, contributing over $300 million to its backlog and solidifying its market leadership in Angola and the U.S. Gulf.

Key takeaways
  • Added over $300 million to backlog through new contracts for five rigs, enhancing revenue visibility through 2026.
  • Achieved exceptional technical uptime of over 99.7% for rigs in the Sonadrill joint venture.
  • Secured direct continuation contracts for the West Vela and Sevan Louisiana in the U.S. Gulf, underscoring strong customer relationships.
  • Highlighted commitment to operational excellence, with plans to enhance rig capabilities through new technologies like managed pressure drilling.
  • Positive market outlook with increasing global tendering activity and renewed focus on offshore investment by oil majors.
More info
Vivid Seats Inc. Class A Common Stock logo
SE
Vivid Seats Inc. Class A Common Stock
SEAT
Q3 2025
Reported:

Vivid Seats delivered a solid recovery in its third quarter, highlighted by a leadership transition and a renewed focus on enhancing its app value proposition, positioning the company for sustained long-term growth.

Key takeaways
  • App users showed double-digit sequential growth, contributing to a return to year-over-year gross order value (GOV) growth.
  • Leadership transition announced, with Lawrence Fey stepping in as CEO to drive the company’s strategic vision.
  • Significant cost reduction program doubled targets from $25 million to $60 million, with strong progress already made.
  • Corporate simplification executed to improve operational efficiency, yielding up to $180 million in potential tax savings.
  • Renewed ESPN partnership aims to expand brand awareness and reach through a national marketing campaign.
More info
Senseonics Holdings, Inc. logo
SE
Senseonics Holdings, Inc.
SENS
Q3 2025
Reported:

Senseonics reported a robust 90% year-over-year revenue growth in Q3 2025, driven by surging demand for its Eversense 365 continuous glucose monitor and enhanced direct-to-consumer marketing initiatives.

Key takeaways
  • New patient shipments skyrocketed by 160% year-over-year, fueling record high quarterly new patient starts.
  • Strategic memorandum signed with Ascensia Diabetes Care to regain Eversense commercialization control, enhancing operational strategy.
  • Direct-to-consumer marketing efforts resulted in a 300% increase in patient leads year-over-year, with 60% of new patients sourced from DTC advertising.
  • The total number of providers prescribing Eversense grew by over 55% year-over-year, reflecting increased market penetration and confidence in the product.
  • Continued expansion of Eon Care's network, accounting for approximately 25% of nationwide insertions, is expected to bolster future access and adoption of Eversense 365.
More info
Sezzle Inc. Common Stock logo
SE
Sezzle Inc. Common Stock
SEZL
Q3 2025
Reported:

Sezzle Inc. delivered strong third-quarter results with 67% year-on-year revenue growth and a net income margin exceeding 22%, reflecting robust demand and effective product enhancements.

Key takeaways
  • Revenue increased by 67% year-on-year, driven by the successful launch of new features aimed at enhancing consumer engagement.
  • Net income margin for Q3 surpassed 22%, while return on equity exceeded 100% over the past 12 months.
  • Significant growth in Monthly On-demand & Subscribers (MODS) metric, with almost 50% increase year-on-year, despite a slight drop in subscription user count.
  • Recent product features, including the Earn tab, received over 13 million visits, showcasing effective customer interaction and increased usage.
  • EPS and EBITDA guidance for 2025 have been raised, indicating confidence in future performance amid a growing BNPL market.
More info
Sweetgreen, Inc. logo
SG
Sweetgreen, Inc.
SG
Q3 2025
Reported:

Sweetgreen reported Q3 2025 sales of $172.4 million, with a notable decline in same-store sales, as the company navigates operational challenges and focuses on a comprehensive transformation strategy.

Key takeaways
  • Same-store sales fell 9.5%, primarily due to weakened demand in the Northeast and Los Angeles markets.
  • Restaurant level margin was reported at 13.1%, while adjusted EBITDA reflected a loss of $4.4 million.
  • Initiatives under the "Sweet Growth Transformation Plan" include enhancing operational excellence and finalizing menu innovations to better engage customers.
  • Improvements in operational metrics were observed, with about 60% of restaurants now meeting internal performance standards.
  • Upcoming marketing campaigns will focus on brand relevance, particularly in challenged markets like New York, and will spotlight the quality of ingredients used in menu offerings.
More info
Sight Sciences Inc. Common Stock logo
SG
Sight Sciences Inc. Common Stock
SGHT
Q3 2025
Reported:

Sight Sciences delivered a robust Q3 2025 with revenues of $19.9 million, driven by strong adoption of its interventional glaucoma technologies and exciting advancements in its dry eye treatment segment.

Key takeaways
  • Raised full-year 2025 revenue guidance to $76 million to $78 million, reflecting positive momentum.
  • Achieved key reimbursements in the TearCare segment with new fee schedules in place for over 10 million Medicare-covered lives.
  • Experienced sequential growth in Surgical Glaucoma revenue, indicating effective operational execution and market demand.
  • Targeted commercialization efforts underway for TearCare, with a focus on expanding market access and customer advocacy among 6,500 potential adopters.
More info
Sangamo Therapeutics, Inc. logo
SG
Sangamo Therapeutics, Inc.
SGMO
Q3 2025
Reported:

Sangamo Therapeutics reported significant advancements in its clinical pipeline for Fabry disease, highlighted by promising data from its STAAR study and a positive interaction with the FDA regarding its upcoming BLA submission.

Key takeaways
  • Presented compelling clinical data from the STAAR study, showing durable benefits of ST-920, with a mean annualized eGFR slope of nearly 2 at 52 weeks across all patients.
  • FDA meeting confirmed agreement to use eGFR slope as an endpoint for an accelerated approval pathway, with plans for a BLA submission anticipated in early 2026.
  • Initiated the Phase I/II STAND study for chronic neuropathic pain, expanding Sangamo's reach into neurology.
  • Emphasized the strong safety profile and durable efficacy of ST-920, including encouraging cardiac data from treated patients.
  • Focused commitment to addressing unmet needs within the Fabry community, bolstered by patient engagement and feedback.
More info
SIGA Technologies, Inc. logo
SI
SIGA Technologies, Inc.
SIGA
Q3 2025
Reported:

SIGA Technologies reported a solid third quarter, with product revenues totaling approximately $86 million year-to-date, reflecting continued government engagement for smallpox antiviral procurement amid evolving bioterrorism concerns.

Key takeaways
  • Year-to-date product revenue was approximately $86 million, driven by strong oral and IV TPOXX sales.
  • Approximately $26 million in outstanding U.S. government orders, primarily for IV TPOXX, expected to be delivered in 2026.
  • Ongoing discussions regarding future procurement of TPOXX highlight the U.S. government's commitment to bioterrorism preparedness amidst a pending government shutdown.
  • SIGA is progressing on pediatric formulation development and an FDA submission for post-exposure prophylaxis (PEP) planned for 2026, despite some delays due to the shutdown.
  • International sales opportunities are anticipated for 2026 as global health security strategies evolve in response to bioterrorism threats.
More info
Savaria Corporation logo
SI
Savaria Corporation
SIS.TO
Q3 2025
Reported:

Savaria Corporation achieved a record 21.2% adjusted EBITDA margin in Q3 2025, driven by operational improvements and strong performance in the Accessibility segment.

Key takeaways
  • Revenue rose 5.2% year-over-year to $224.8 million, aided by organic growth and acquisitions.
  • Gross margin improved by 220 basis points to 39.2%, reflecting successful operational efficiencies from the Savaria One initiative.
  • Q3 net earnings jumped 74% to $19.5 million, resulting in earnings per share of $0.27.
  • High backlog levels signal a strong Q4 outlook, despite overall growth being below targets.
  • Net debt-to-EBITDA ratio improved to 1.19, with $290 million available for future investments.
More info
Stabilis Solutions, Inc. logo
SL
Stabilis Solutions, Inc.
SLNG
Q3 2025
Reported:

Stabilis Solutions reported a strong third quarter in 2025, achieving a 15% year-over-year revenue increase driven by robust demand in aerospace, marine, and power generation sectors.

Key takeaways
  • Revenue grew to $20.3 million, with LNG gallons sold up 21% year-over-year.
  • Aerospace revenues surged 88%, with marine and power generation up 32% and 31%, respectively.
  • Secured a historic 10-year marine bunkering contract, potentially representing 40% of planned LNG facility capacity in Galveston, Texas.
  • Adjusted EBITDA reached $2.9 million, reflecting a slight margin decline to 14.3% due to the conclusion of a high-margin industrial contract.
  • Strong liquidity of $15.5 million at quarter end, with a net positive cash position after debt obligations.
More info
SLR Investment Corp. logo
SL
SLR Investment Corp.
SLRC
Q3 2025
Reported:

SLR Investment Corporation reported third-quarter net investment income of $0.40 per share, reflecting strong stability and a year-over-year increase in new originations, despite a competitive private credit landscape.

Key takeaways
  • Net income for Q3 was $0.43 per share, achieving a 9.4% annualized return on equity.
  • SLRC originated $447 million in new investments, a 12.7% increase year-over-year, marking the second highest quarter of originations in the company's history.
  • Approximately 93% of new originations were in specialty finance, enhancing the portfolio’s risk-adjusted return profiles and improving credit documentation integrity.
  • The organization is strategically focusing on asset-based lending (ABL) due to strong demand and high barriers to entry, successfully doubling ABL volume year-to-date compared to 2024.
  • The hiring of Mac Fowle as President of Asset-Based Lending reflects the firm's commitment to expanding its ABL capabilities amid growing opportunities in the private credit market.
More info
Smith Micro Software, Inc. logo
SM
Smith Micro Software, Inc.
SMSI
Q3 2025
Reported:

Smith Micro Software’s third-quarter results reflect a strategic reorganization aimed at enhancing efficiency and setting the stage for a return to profitability, despite a slight revenue decline year-over-year.

Key takeaways
  • Revenue decreased to $4.3 million, down 6% year-over-year and slightly below guidance due to delays in launching a new SafePath feature.
  • The company implemented strategic cost reductions expected to save approximately $7.2 million annually, affecting about 30% of its workforce.
  • Anticipates reaching breakeven by mid-2026, supported by a recent $2.7 million financing round to bolster operational efforts.
  • Strong pipeline growth in North America and Europe, with a focus on family subscribers representing a high-value market opportunity for carriers.
More info
Sonos, Inc. logo
SO
Sonos, Inc.
SONO
Q4 2025
Reported:

Sonos delivered a strong finish to fiscal 2025 with a 13% year-over-year revenue growth and positive adjusted EBITDA, all while laying the groundwork for a revitalized growth strategy.

Key takeaways
  • Revenues increased by 13% year-over-year, reflecting effective operational efficiencies and financial discipline.
  • The company announced the appointment of Colleen DeCourcy as the new Chief Marketing Officer, enhancing its leadership team.
  • Sonos is pivoting towards a unified sound system strategy aimed at integrating diverse audio experiences across households, setting the stage for long-term growth.
  • Average multiproduct households increased to 4.49, indicating strong consumer engagement; the company sees a pathway to significantly expand lifetime value within its existing customer base.
  • Sonos holds just 6% of the $24 billion global premium audio market, with ambitious plans to capture a larger share through innovative products and deeper customer relationships.
More info
Sensus Healthcare, Inc. logo
SR
Sensus Healthcare, Inc.
SRTS
Q3 2025
Reported:

Sensus Healthcare's Q3 2025 performance showcases significant advancements, including the introduction of new CPT codes for superficial radiotherapy, which are expected to drive increased demand and enhanced reimbursement.

Key takeaways
  • CMS has established new dedicated CPT codes for superficial radiotherapy, promising over 300% reimbursement increases per treatment fraction.
  • The company recorded a 20% growth in FDA treatment volumes from Q2, marking the third consecutive quarter of double-digit growth; total treatments rose 157% since the program's launch.
  • Sensus shipped 16 SRT systems in Q3, reaching over 900 systems sold globally, with an expectation to hit 1,000 by 2026.
  • Strong cash position increased to $24.5 million, aided by improved working capital management, positioning the company to meet anticipated demand.
More info
TBC Bank Group PLC logo
TB
TBC Bank Group PLC
TBCG.L
Q3 2025
Reported:

TBC delivered a robust 6% year-on-year net profit growth to GEL 368 million in Q3 2025, marking a record quarterly performance, driven by strong returns in both Georgia and Uzbekistan.

Key takeaways
  • Return on equity stood at an impressive 24.4%, with Georgia’s return at over 24% and Uzbekistan’s exceeding 23%.
  • Revenue rose by 7% year-on-year, supported by a 9% increase in gross loans in Georgia and a nearly doubled loan book in Uzbekistan.
  • The digital ecosystem thrived, boasting nearly 22 million registered users and 1.2 million monthly active users in Georgia, indicating strong customer engagement.
  • The Board declared a quarterly dividend of GEL 1.75 per share, totaling GEL 5 for the first nine months of 2025.
  • Despite challenges in Uzbekistan impacting net profit guidance, the management remains optimistic about long-term growth potential.
More info
BlackRock TCP Capital Corp. logo
TC
BlackRock TCP Capital Corp.
TCPC
Q3 2025
Reported:

BlackRock TCP Capital Corp. maintained its NAV at $8.71 in Q3 2025 while improving nonaccruals to 3.5% of the portfolio, although challenges with the Renovo investment may impact future earnings.

Key takeaways
  • Successful resolution of challenged credits with a drop in nonaccrual investments from 5.6% to 3.5%.
  • Declared a consistent third-quarter dividend of $0.25 per share, reflecting stability amid market fluctuations.
  • Increased deal activity with a 20% rise in reviewed opportunities, showcasing enhanced access through the BlackRock and HPS Private Financing Solutions platform.
  • Notable portfolio gains, particularly with NEP Group, which upgraded TCPC's investment from a second lien to a first lien term loan.
  • Anticipated write-down of the Renovo investment, projected to reduce NAV by approximately $0.15 per share in Q4 2025.
More info
Tecnoglass Inc. logo
TG
Tecnoglass Inc.
TGLS
Q3 2025
Reported:

Tecnoglass posted a record revenue of $260.5 million in Q3 2025, reflecting a 9.3% year-over-year increase driven by strong performance in both residential and commercial segments, despite ongoing macroeconomic challenges.

Key takeaways
  • Single-family residential revenue grew 3.4% year-over-year to $113.5 million, aided by recently implemented pricing initiatives.
  • Multifamily and commercial revenue surged 14.3% year-over-year to $147 million, contributing to a record backlog of $1.3 billion, up over 20%.
  • Maintained strong profitability with a gross margin of 42.7% and an adjusted EBITDA margin of 30.4%.
  • Returned significant capital to shareholders, repurchasing $30 million in shares and paying $7 million in dividends during the quarter.
  • Healthy book-to-bill ratio remained at 1.3x, demonstrating consistent order activity and market share gains.
More info
Alpha Teknova Inc. Common Stock logo
TK
Alpha Teknova Inc. Common Stock
TKNO
Q3 2025
Reported:

Teknova reported robust financial performance in Q3 2025, with a 9% year-over-year revenue growth driven primarily by strong sales in its Lab Essentials segment, indicating sustained operational excellence.

Key takeaways
  • Revenue reached $10.5 million, up from $9.6 million in Q3 2024, marking the fifth consecutive quarter of growth.
  • Lab Essentials revenue grew 16% to $8.3 million, reflecting a healthy increase in average revenue per customer.
  • Clinical Solutions revenue decreased 13% to $1.7 million due to lower average revenue per customer, although customer count increased.
  • Operational enhancements are underway, anticipated to improve efficiency and scale revenue to over $200 million by 2026 without significant capex.
  • Continued focus on expanding the Clinical Solutions customer base expected to drive long-term growth through to 2026 and beyond.
More info
TKO Group Holdings, Inc. logo
TK
TKO Group Holdings, Inc.
TKO
Q3 2025
Reported:

TKO reported a transformative Q3 2025, highlighted by landmark media rights agreements, a 100% increase in cash dividends, and a $1 billion stock buyback, reinforcing strong growth trajectories across its operations.

Key takeaways
  • Secured a historic 7-year, $7.7 billion media rights deal with Paramount for UFC, doubling previous average annual value.
  • Launched a 5-year partnership with ESPN for WWE, resulting in over 1.8x increase in value and expanding audience reach.
  • Established records in live events, with UFC and WWE achieving significant ticket sales and audience viewership milestones.
  • Continued strong performance in brand partnerships, with WWE attracting major new sponsors and PBR delivering record viewership on CBS.
  • Increased full-year guidance signals confidence in sustainable long-term growth amid a robust sports content landscape.
More info
Tandem Diabetes Care, Inc. logo
TN
Tandem Diabetes Care, Inc.
TNDM
Q3 2025
Reported:

Tandem Diabetes Care reported record Q3 sales, driven by significant advancements in commercial operations and successful product launches, positioning the company for future growth.

Key takeaways
  • Record Q3 sales driven by improved sales productivity and an effective commercial transformation in the U.S.
  • Successful launch of t:slim X2 with Abbott's FreeStyle Libre 3 Plus integration, enhancing user access to advanced diabetes management technology.
  • Expansion of Type 2 diabetes efforts showing promising results, doubling the company's addressable market in the U.S.
  • Direct sales initiatives in Europe slated to begin in early 2026, enhancing growth potential and margin expansion.
  • Increased pharmacy benefit coverage for Tandem Mobi reaching over 40% of U.S. lives, marking a significant milestone in revenue generation.
More info
Texas Pacific Land Corporation logo
TP
Texas Pacific Land Corporation
TPL
Q3 2025
Reported:

Texas Pacific Land Corporation achieved record revenue of over $200 million in Q3 2025, driven by substantial growth in oil and gas royalties and water sales, despite challenging benchmark pricing.

Key takeaways
  • Oil and gas royalty production reached a record 36,300 barrels of oil equivalent per day, marking a 28% year-over-year increase.
  • Water sales revenue soared to $45 million, representing a 74% sequential growth and a 23% increase year-over-year.
  • Produced water royalty revenues grew to $32 million, up 16% year-over-year.
  • The company's strategy of acquiring mineral and royalty interests is yielding a mid-teens pretax cash flow yield.
  • TPL's investments in water infrastructure position it as a key player in the Permian Basin, solidifying market share despite industry headwinds.
More info
Targa Resources Corp. logo
TR
Targa Resources Corp.
TRGP
Q3 2025
Reported:

Targa Resources Corporation achieved record adjusted EBITDA in Q3 2025, driven by strong Permian volume growth and continued commercial success, positioning the company for significant future cash flow generation.

Key takeaways
  • Adjusted EBITDA for the quarter is expected to be at the top end of guidance due to record natural gas inlet volumes averaging 6.6 billion cubic feet per day.
  • NGL volumes increased by approximately 180,000 barrels per day year-over-year, highlighting robust demand and operational efficiency.
  • Multiple new growth projects announced, including the Speedway NGL transportation expansion and Copperhead gas processing plant, set to enhance capacity and support future growth.
  • Long-term projections indicate a durable increase in free cash flow beginning in 2027 as capital expenditures decrease, despite ongoing growth investments.
  • Strong customer relationships and market positioning forecasted to sustain low double-digit volume growth through 2026.
More info
Tronox Holdings plc logo
TR
Tronox Holdings plc
TROX
Q3 2025
Reported:

Tronox Holdings plc reported a challenging Q3 2025 with a 13% decline in revenues to $699 million, driven by weaker demand and competitive pressures in the TiO2 and zircon markets, leading to a net loss of $99 million.

Key takeaways
  • Secured $400 million in senior secured notes, enhancing liquidity amidst ongoing market challenges.
  • Cost improvement program ahead of schedule, expected to achieve over $60 million in annualized savings by year-end 2025.
  • Anticipated operational adjustments, including idling plants and reducing inventory, projected to yield $25 million to $30 million in cash benefits in Q4.
  • Continued pressure observed in TiO2 and zircon sales, with revenues down 11% and 20% year-over-year, respectively.
  • Strategic focus on diversifying supply chains and capitalizing on potential rare earth mineral opportunities.
More info
trivago N.V. logo
TR
trivago N.V.
TRVG
Q3 2025
Reported:

Trivago reported robust Q3 2025 results with a 13% year-over-year revenue increase and 18% growth in adjusted EBITDA, demonstrating sustained momentum despite foreign exchange challenges.

Key takeaways
  • Achieved 13% revenue growth, marking the fourth consecutive quarter of double-digit growth.
  • Strong branded traffic revenue, with significant marketing efficiency improvements from new AI-powered initiatives featuring brand ambassador Jürgen Klopp.
  • Confidence maintained for mid-teens revenue growth for the full year and positive adjusted EBITDA of at least EUR 10 million.
  • Enhanced hotel search experience and continued investment in partnerships to create value amid economic uncertainties.
  • Expect a promising Q4, bolstered by a disciplined strategy focusing on core markets and optimization ahead of a winter marketing campaign.
More info
The Trade Desk, Inc. logo
TT
The Trade Desk, Inc.
TTD
Q3 2025
Reported:

The Trade Desk reported robust Q3 2025 performance with revenue growth of 18%, driven primarily by the significant expansion in its Connected TV (CTV) and retail media segments.

Key takeaways
  • Revenue increased by 18% year-over-year; 22% growth excluding political spend.
  • CTV remains the fastest-growing channel, projected to dominate programmatic buying models.
  • Rapid growth of retail media indicates strong adoption of programmatic advertising across various verticals.
  • The shift toward an open Internet fosters competitive supply chains, enhancing price discovery and advertiser value.
  • AI innovations are bolstering effectiveness and efficiency in digital advertising, shifting focus away from walled gardens.
More info
10x Genomics, Inc. logo
TX
10x Genomics, Inc.
TXG
Q3 2025
Reported:

10X Genomics reported a solid third quarter, exceeding revenue expectations with $149 million driven by strong demand for both single-cell and spatial biology products despite ongoing macroeconomic challenges.

Key takeaways
  • Total revenue of $149 million surpassed guidance, reflecting strong execution amid macro pressures.
  • Significant year-over-year growth in spatial consumables, particularly for Xenium, continued to drive momentum.
  • Expansion of product offerings, including new Chromium Flex and Xenium protein, is anticipated to enhance market adoption and streamline workflows.
  • Ended the quarter with a robust $482 million cash position, ensuring flexibility for strategic investments.
  • Customer sentiment indicates sustained cautious spending behavior, particularly concerning capital expenditures.
More info
Texas Roadhouse, Inc. logo
TX
Texas Roadhouse, Inc.
TXRH
Q3 2025
Reported:

Texas Roadhouse delivered record third-quarter revenues of $1.4 billion, driven by strong same-store sales growth and successful expansion efforts across its restaurant brands.

Key takeaways
  • Revenue increased significantly, achieving the highest quarterly growth of the year alongside strong traffic and same-store sales.
  • Seven new company-owned locations opened in Q3, contributing to a projected total of approximately 30 new restaurants for 2025.
  • Despite rising commodity prices, especially for beef, there was no significant impact on guest behavior post-menu price increase, indicating robust consumer demand.
  • Continued momentum in the To-Go business and retail strategy, with presence across 120,000 retail outlets bolstering brand visibility.
  • Cash flow from operations rose to $144 million, supporting ongoing development and capital allocation strategies.
More info
Unisys Corporation logo
UI
Unisys Corporation
UIS
Q3 2025
Reported:

Unisys Corporation demonstrated resilience in Q3 2025, outperforming operating margin expectations while navigating revenue headwinds largely due to timing issues and macroeconomic uncertainty.

Key takeaways
  • Achieved non-GAAP operating profit margin guidance of 8% to 9%, with full-year pre-pension free cash flow expected to reach $110 million.
  • Increased License & Support (L&S) revenue expectations to $430 million for the year, driven by strong client retention and software consumption trends.
  • Total contract value for new business increased 15% year-over-year, suggesting solid client renewals despite a challenging pricing environment.
  • Continued focus on pension strategy led to a significant reduction in U.S. pension liabilities, with over $300 million removed through an annuity purchase.
  • Adjustments in project timing and client budget constraints may impact near-term revenue growth, although a long-term growth strategy remains in place.
More info
Frontier Group Holdings, Inc. logo
UL
Frontier Group Holdings, Inc.
ULCC
Q3 2025
Reported:

Frontier Group Holdings reported a commendable third quarter for 2025, with revenue growth driven by improved efficiencies and a strategic reduction in capacity. Despite competitive pressures, the company anticipates a favorable shift in the market landscape.

Key takeaways
  • Total revenue increased to $886 million, with revenue per passenger up 1% year-over-year amid 4% lower capacity.
  • The operational reliability is underscored by a completion factor ranking third among domestic carriers for September.
  • Announced 42 new routes, targeting expansion in major U.S. metros and new international destinations through early 2026.
  • Loyalty program revenues per passenger surged over 40% year-over-year, reflecting successful enhancements aimed at higher-income customers.
  • Liquidity remained solid at $691 million, with additional financing secured through a $105 million note issuance related to spare parts and tooling.
More info
Unusual Machines, Inc. logo
UM
Unusual Machines, Inc.
UMAC
Q3 2025
Reported:

Unusual Machines reported its first profitable quarter with record revenues of $2.1 million, marking a strategic shift towards enterprise sales and a gross margin expansion.

Key takeaways
  • Achieved $2.1 million in quarterly revenue, a 39% increase year-over-year, with year-to-date revenue up 55% at $6.3 million.
  • First quarter where over 50% of revenue originated from enterprise sales, with $16 million in future purchase orders secured.
  • Gross margin improved from 28% to 34% year-to-date, reflecting successful transition from retail to enterprise focus.
  • Cash balance strengthened to over $130 million, after raising $72 million through an ATM offering, providing ample liquidity for growth initiatives.
  • Employee headcount increased from 19 to over 60, showcasing rapid scaling in line with expanding operational demands.
More info
UroGen Pharma Ltd. logo
UR
UroGen Pharma Ltd.
URGN
Q3 2025
Reported:

UroGen Pharma reported strong third-quarter results, with a notable increase in ZUSDURI's preliminary demand, setting the stage for future growth in an estimated $5 billion market.

Key takeaways
  • October's preliminary demand revenue for ZUSDURI more than doubled compared to the previous three months, indicating a solid uptick in adoption.
  • JELMYTO achieved $25.7 million in net product revenue, a 13% increase year-over-year, illustrating sustained market confidence.
  • The positive clinical performance of ZUSDURI, with an 80% complete response rate at three months, positions it as a likely standard of care for bladder cancer.
  • UroGen is on track to submit a New Drug Application (NDA) for UGN-103 in the second half of 2026, with FDA approval anticipated in 2027.
  • Anticipation of a permanent product-specific J-code for ZUSDURI effective January 1, 2026, could accelerate adoption and reimbursement processes.
More info
US Foods Holding Corp. logo
US
US Foods Holding Corp.
USFD
Q3 2025
Reported:

US Foods Holding Corporation reported strong Q3 2025 results, with net sales growth of 4.4% and a notable 10.9% increase in adjusted EBITDA, reflecting solid execution and a successful market position.

Key takeaways
  • Achieved 29 basis points of adjusted EBITDA margin expansion and a 26.7% growth in adjusted EPS year-to-date.
  • Independent case volume grew 3.9%, with strong momentum and a net new account growth rate of 4.4%, marking the highest since Q2 2023.
  • Announced acquisition of Shetakis, an independent food distributor in Las Vegas, aligning with the company’s strategic M&A focus.
  • Improved safety metrics with a 16% reduction in injury and accident rates, reinforcing corporate commitment to associate well-being.
More info
Wynn Resorts, Limited logo
WY
Wynn Resorts, Limited
WYNN
Q3 2025
Reported:

Wynn Resorts reported a solid Q3 2025 performance, with significant growth in gaming revenues and strong EBITDAR driven by market share gains across its key locations, despite some operational challenges.

Key takeaways
  • Wynn Las Vegas achieved EBITDA growth of 3% to $211 million, with casino revenues up 10% and a strategic focus on preserving ADR contributing to flat hotel revenue.
  • Encore Boston Harbor generated $58 million in EBITDAR, with slot revenues increasing over 5% year-on-year amidst controlled operating expenses.
  • Macau operations delivered $308 million in EBITDAR, bolstered by a VIP hold benefit, with mass volumes up 15% year-on-year despite weather disruptions.
  • Upcoming projects, including expansions in Macau and the development of Wynn Al Marjan Island, position the company for future growth and capitalize on rising premium market demand.
  • While facing some expected headwinds from property renovations, the long-term outlook remains positive, bolstered by strong demand signals in Las Vegas and Macau.
More info
Anacortes Mining Corp. logo
XY
Anacortes Mining Corp.
XYZ
Q3 2025
Reported:

Block's Q3 2025 results surpassed expectations, driven by a robust 18% year-over-year growth in gross profit, predominantly fueled by Cash App's expanding user base and product offerings.

Key takeaways
  • Gross profit reached $2.66 billion, a notable acceleration from previous quarters, primarily thanks to a 24% increase in Cash App's gross profit.
  • Cash App's monthly active users grew to 58 million, bolstered by enhancements in user experience and engagement initiatives.
  • New financial products, including expanded Cash App Borrow and the post-purchase Buy Now Pay Later feature, achieved significant momentum with a 134% year-over-year growth in loans.
  • Square's gross profit rose 9% year-over-year as the company strengthened its market position among larger sellers and in international markets.
  • Introducing AI-driven tools and integrated solutions, Block aims to enhance seller operations and improve service delivery, positioning itself favorably for future growth.
More info
Yelp Inc. logo
YE
Yelp Inc.
YELP
Q3 2025
Reported:

Yelp Inc. reported strong Q3 2025 results with record net revenue of $376 million, driven by a 7% year-over-year increase in Services revenue, despite challenges in the Restaurant, Retail, and Other categories.

Key takeaways
  • Net income rose 2% year-over-year to $39 million, maintaining a 10% net income margin.
  • Adjusted EBITDA margin stood at 26%, with efficacy driven by disciplined expense management.
  • Significant growth in AI-led initiatives, including a 400% increase in project submissions via Yelp Assistant.
  • New partnership with DoorDash expands food ordering capabilities to over 500,000 restaurants, expected to generate incremental revenue.
  • Overall decline of 2% in RR&O revenue indicates persistent macro pressures, affecting paying advertising locations.
More info
Zai Lab Limited logo
ZL
Zai Lab Limited
ZLAB
Q3 2025
Reported:

Zai Lab's Q3 2025 results reflect strong advancements in its clinical pipeline, particularly the promising early data for Zoci, while the company's commercial operations in China demonstrate steady growth despite a complex environment.

Key takeaways
  • Zoci (ZL-1310) shows a 68% overall response rate and 94% disease control rate in heavily pretreated extensive stage small cell lung cancer patients, suggesting strong efficacy potential.
  • The company is on track for its first global approval by 2027 or early 2028, with ongoing enrollment in registrational Phase III trials.
  • Zai Lab reports continued profitability within its commercial business in China, although growth is at a slower pace than anticipated amid a dynamic market.
  • Significant advancements in the pipeline include the entry of IL-13/IL-31 bispecific antibody into Phase I and continued progress with innovative assets and late-stage programs.
  • The company emphasizes a commitment to delivering impactful therapies and long-term value for shareholders while navigating regulatory and competitive challenges.
More info

📊 Community

See what investors are trading, holding, and sharing

🌐
All
📈
Stock
📊
ETF
🏦
Mutual Fund
🪙
Crypto
💱
Forex
# Asset Price Community % Type Currency Sector